Zinc-Mediated Dimerization of Proteins through a -CxCxxxxCxC- Sequence by Collins, Tyler
Duquesne University
Duquesne Scholarship Collection
Electronic Theses and Dissertations
2009
Zinc-Mediated Dimerization of Proteins through a
-CxCxxxxCxC- Sequence
Tyler Collins
Follow this and additional works at: https://dsc.duq.edu/etd
This Immediate Access is brought to you for free and open access by Duquesne Scholarship Collection. It has been accepted for inclusion in Electronic
Theses and Dissertations by an authorized administrator of Duquesne Scholarship Collection. For more information, please contact
phillipsg@duq.edu.
Recommended Citation
Collins, T. (2009). Zinc-Mediated Dimerization of Proteins through a -CxCxxxxCxC- Sequence (Doctoral dissertation, Duquesne
University). Retrieved from https://dsc.duq.edu/etd/424
 
 
 
 
ZINC-MEDIATED DIMERIZATION OF PROTEINS THROUGH A  
 
–CxCxxxxCxC– SEQUENCE 
 
 
 
 
 
 
 
 
 
A Dissertation 
 
Submitted to the Bayer School of  
 
Natural and Environmental Sciences 
 
 
 
 
 
Duquesne University 
 
 
 
In partial fulfillment of the requirements for 
 
the degree of Doctor of Philosophy 
 
 
 
By 
 
Tyler Christian Collins 
 
 
 
December 2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright 
 
Tyler Christian Collins 
 
 
 
2009 
iii 
 
 
 
 
ZINC-MEDIATED DIMERIZATION OF PROTEINS THROUGH A  
 
–CxCxxxxCxC– SEQUENCE 
 
 
 
 
 
 
 
By 
 
Tyler Christian Collins 
 
Approved October 9, 2009 
 
 
 
________________________________ 
Charles T. Dameron, Ph.D. 
Associate Professor 
(Committee Chair) 
________________________________ 
Mihaela Rita Mihailescu, Ph.D. 
Assistant Professor 
(Committee Member) 
________________________________ 
Jeffry D. Madura, Ph.D. 
Professor  
(Committee Member) 
________________________________ 
Jana Patton-Vogt, Ph.D. 
Associate Professor of Biology 
(External Reviewer) 
________________________________ 
David W. Seybert, Ph.D. 
Dean, Bayer School of Natural and 
Environmental  Sciences 
 
________________________________ 
Jeffry D. Madura, Ph.D. 
Chair, Department of Chemistry and 
Biochemistry 
 
 
iv 
ABSTRACT 
 
 
 
ZINC-MEDIATED DIMERIZATION OF PROTEINS THROUGH A  
 
–CxCxxxxCxC– SEQUENCE 
 
 
 
 
 
 
 
By 
 
Tyler Christian Collins 
 
December 2009 
 
 
 
Dissertation supervised by Professor Charles T. Dameron 
 
 Dimerization of cellular proteins has become an intense field of study due to its 
importance in signal transduction and gene expression, amongst many other functions.  
Arguably the most intriguing quality regarding dimerization is the high incidence of 
simultaneous dimeric events occurring within the cell, where each constructed dimer 
individually controls a single pathway with high specificity.  Additionally, the 
discoveries of new motifs possessing this seemingly common functionality participate in 
truly unique and often poorly understood mechanisms.  CopY, a metal-responsive 
bacterial repressor from Enterococcus hirae possesses distinctive dimerization properties.  
We show that this cysteine metal-binding motif, which contains a metal-reactive C-
terminal –CxCxxxxCxC- site used for sensing high Cu(I), is also indispensible for dimer 
formation in its Zn(II) form in vivo and in vitro.  Paired adjacent to the cysteine motif is a 
v 
repeating aliphatic sequence that mimics a coiled-coil, where the two combined 
contributors produce a dimer of low micromolar affinity.  Removal of the metal-binding 
site perturbs the dimer’s stability, resulting in the loss of specific two-stranded 
dimerization and shifting the complexes equilibrium towards an aggregated state 
according to isothermal titration calorimetry.  This transition illuminates the site’s role in 
organizing quaternary structure.  Protein-fragment complementation assay technology 
was employed to explore the whole dimer’s ability to heterodimerize in an effort to 
establish the level of specificity within the aliphatic-repeat sequence.  The results indicate 
that symmetrical deletions within the aliphatic-repeat produce stronger dimers compared 
to those asymmetrically constructed.  In all cases, metal-binding site was necessary for 
successful construction of high-affinity dimers according to both methods. 
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Chapter 1 
 
Introduction 
 
1.1. Metals Participate in Specific Protein-Protein Interactions 
The quaternary structure of proteins varies substantially across biology, ranging from 
stably-constructed protein lattices, to rapid signaling cascades which rely on protein-
protein recognition1-3.  A phenomenon which accounts for many biological events within 
the cell, protein-protein interactions control the survival and health of all organisms 
living on the planet.  Protein-protein interactions can be globally defined through the use 
of either individual or groups of amino acid residues originating from two or more 
separate proteins which form reversible or irreversible bonds which each other1-3.  
Typically, specificity is built within a residue or a sequence of residues that participate in 
the interaction, or in the general architecture of a motif which harbors those residues so 
the desired pathway is properly signaled. The larger configurations formed from the 
construction of protein-protein interactions may generally function as cellular support 
structures, scaffolds for recruiting other proteins in a cooperative manner, or as switches 
which govern downstream signaling pathways4, 5.  Protein-protein interactions can be 
used in more application-based scenarios, such as medical diagnostics, kit-based 
molecular biology techniques which induce dimerization or as targets to create drugs.  
This research aims to investigate the relation between the coordination of metal ions 
within proteins, and its influence upon the formation of dimers. 
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The class of proteins that directly control metal detoxification systems in bacteria are 
metal-sensing repressors.   Metal-responsive transcription factors function through 
sensing of the specific metal in excess.  To maintain homeostasis, the cell is signaled to 
counteract toxicity through the expression of detoxifying proteins built specifically to 
bind the particular metal6, 7.  Upon metal-binding to the repressor, conformational 
changes in global structure are produced through the rearrangement of bonds to 
accommodate the metal, therefore disrupting protein-nucleic acid interactions8.  
Seemingly miniscule changes in the coordination geometry within a protein induce larger 
cellular responses which enable a cell to react quickly in order to regain equilibrium.  The 
reality is that several metal-sensing repressors are responding simultaneously to deficits 
or surpluses of toxic metals at any time.  Specificity of the metals bound to the governing 
repressors allows the cell to cope with possibly toxic levels of multiple metal ions at 
once.  Understanding each dimeric interaction within the cell helps establish how vital 
specificity is to the survival of the cell and as a consequence, whole organisms. 
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1.2. Examples of Metal-Responsive Dimerization: The Focus of this 
Research 
 The family of metalloregulatory proteins being reviewed is identified as 
prokaryotic metal-sensory transcriptional activators.  The metal-sensing family of 
transcriptional repressors controls the production of proteins in charge of the removal of 
specific metal ions when in excessive cellular concentrations.  Such bacterial systems 
exist for Cd(II), Pb(II), Co(II), Ni(II), Zn(II) and Cu(I) to name a few9, 10.  Specificity 
with regard to the correct binding of metal to its parent regulatory repressor is critical for 
the cell to survive and maintain homeostasis.  Systems such as these originating from 
bacterial pathogens are arduously studied as understanding these pathways may lead 
towards new antimicrobial drug targets. 
 The process of molecular recognition of metal ions in the cell must be tightly 
regulated in order to fulfill cellular requirements without initiating oxidative stress11.  The 
cell possesses pathways that circumvent the potential problems which arise regarding the 
specificity metal-ion binding to its macromolecular target.  Protein-protein interactions 
facilitate the specificity associated with the introduction, trafficking and regulation of 
metal ions within the cell12, 13.  For instance, import and export pumps embedded in the 
cellular membrane serve as transporters which can negotiate the specificity of binding the 
correct ion based upon nuclei diameter, charge and other elemental parameters13-15.  From 
the moment the correct ion enters the cytoplasm, protein-protein interactions govern its 
intracellular fate, whether it be motioned towards a specific enzyme for structural, 
catalytic or redox purposes, or to activate its own metabolism11, 13, 15.  The dialogue to 
follow will focus upon those promoter-bound regulatory elements which exist as 
4 
homodimers when affixed to their nucleic-acid recognition sequence.  A common feature 
of prokaryotic metallo-regulatory repressors is that the activating metal-binding sites lie 
at the dimerization interface7, 16, 17.  Ligands responsible for coordinating these metal ions 
are usually cysteinyl thiolates where binding of a single ion may utilize thiolates from 
only one monomer or from both. 
 
1.3. CopY from Enterococcus hirae: A Unique Metallo-Regulatory Protein 
 The CopY protein from Enterococcus hirae, a gram-positive bacterium, is an 
example of a complicated quaternary protein fold, utilized within a unicellular bacterium.  
Better known as a paradigm for copper homeostasis, the E. hirae copper system deserves 
more detailed attention regarding how each participant functions the way it does12, 15.  
Metal-responsive repressors are extremely important due to their relationship in 
controlling the concentration of radical-inducing metals that enter the cell, which makes 
CopY an attractive example as a metal sensor.  
 
1.3.1. CopY’s Involvement in Prokaryotic Copper Metabolism  
 CopY is a metal-requiring repressor protein of the cop operon in E. hirae, 
controlling the expression of four indispensable cop proteins13, 15, 18, 19.  Together, all four 
proteins CopY, CopZ, a Cu(I) chaperone, and membrane-spanning ATPases CopA and 
CopB, function in maintaining Cu(I) concentrations at functional, non-toxic levels7, 8, 12.  
Generally, CopY requires one bound Zn(II) per monomer within its C-terminal metal 
binding site which is comprised of four cysteines in a –CxCxxxxCxC– amino acid motif7, 
8, 13, 20
.  It is hypothesized that the Zn(II) is necessary for initial dimer formation and to 
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provide the metal binding site with the correct structure in order to accept two Cu(I) 
ions15, 19.  Upon the influx of metal, two moles of Cu(I) displace the one Zn(II) within 
CopY’s metal binding site8, 13, 15.  Metal-induced transformation subsequently disrupts the 
repressor’s affinity for the cop promoter and also relaxes the metal binding motif’s 
backbone to accommodate two Cu(I) in place of one Zn(II)6, 13, 21-23.  Previously, its 
dimerization contains contributions from its metal-binding site and four adjacent β–
branched hydrophobic residues.  The series of four leucine and isoleucine residues is part 
of a larger sequence containing hydrophobic residues evenly-spaced apart.  The whole 
region, termed an aliphatic-repeat, has not been investigated with regard to whole 
contributions to CopY’s dimerization.  Although CopY metal binding site is distinct with 
respect to how it reacts to changes in cellular metal influx, there are other regions of the 
protein which may influence its dimerization. 
 
 1.3.2. CopY Function and Domain Composition 
 CopY is a regulatory protein that can adopt one of two metal-binding 
arrangements within its –CxCxxxxCxC- site, where its metal coordination governs its 
DNA-binding functionality6-8, 24.  In its promoter-bound “repressed” state, one zinc(II) 
occupies the CopY metal binding motif in a tetrahedral metal-thiolate configuration7, 15.  
Averaged metal-thiolate bond distances have been measured using extended x-ray 
absorption fine structure (EXAFS) spectroscopy, confirming the metal-binding location 
of Zn(II) or Cu(I) in CopY’s C-terminus15.  CopY’s promoter-induced state produces a 
conformation change resultant from the replacement of its bound Zn(II) with two moles 
of Cu(I) from the CopZ chaperone15, 21, 25, 26.  EXAFS was used to measure the average 
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bond distances between both metal-thiolate bonds and bonds between metal ions15.  All 
current studies suggest an indispensable role for CopY’s metal binding motif for 
regulating its intracellular Cu(I), but reports are not available on CopY’s metal-regulated 
dimerization capabilities.  Recently, it has been hypothesized that other regions of CopY 
may also participate in stabilizing the dimer.   
 The aliphatic repeat is composed of a series of β-branched aliphatic amino acids 
such as leucine, isoleucine and valine, spaced in a fashion that approximates a well-
documented alpha-helical motif known as a coiled-coil.  Stabilization of the coiled coil 
motif is created through exterior salt bridge formation via oppositely-charged residues 
which effectively shields the buried aliphatic interior of the hydrophobic core.  Coiled-
coils produce pairwise, or higher order protein-interactions driven by hydrophobic 
effect27-29.  Typically characterized in terms of heptad repeats, hpphppp would represent 
such a primary sequence where “h” represents a hydrophobic amino acid such as a 
leucine, isoleucine or valine where “p” represents a polar residue30-32.  Having a series of 
heptads present within an alpha helix would produce an amphipathic structure with a 
stripe of hydrophobic residues lying on one side.30-32  Combining the latter and its metal 
binding motif, the C-terminal half of CopY is hypothesized to form its dimerization 
domain.  Therefore, the hypothesis states that both the metal-binding site and the 
aliphatic-repeat contribute to the formation of dimers. 
 It has been determined that the C-terminal 38 residues of the CopY repressor are 
sufficient to preserve dimerization of proteins for which it is attached 19.  This section of 
the repressor includes 25 amino acids of aliphatic repeat which include 4-leucine repeats, 
and its metal-binding motif.  In this specific construct, mutation of these four stabilizing 
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residues does not completely abolish dimerization of the 38-mer19.  What does abolish 
dimerization is the combination of the latter, combined with the irreversible modification 
of the 38-mer’s Zn(II)- and Cu(I)-coordinating cysteines 19.  Since it is evident that the 
metal-binding motif is key towards maintaining dimerization, determination of those 
regions contributing affinity is necessary.   
 Spanning as much as 95 residues, CopY’s N-terminal 60 residues can be defined 
as its DNA-binding domain15.  The DNA-binding domain has been characterized based 
upon DNase footprinting experiments along with homology modeling of other DNA-
binding repressor proteins such as the λCro repressor from bacteriophage6, 15.  Such 
protein folds have been grouped as penicillinase repressors which possess helix-turn-
helix motifs33.  In addition, CopY forms a winged helix motif sharing high homology 
with BlaI and MecI from S. aureus, along with B. licheniformis PenI15, 20, 34.  The research 
presented hereafter focuses on the C-terminal 95 CopY residues that have been 
designated its dimerization domain.  Most importantly, the CopY repressor from E. hirae 
is not one-of-a-kind, as other unicellular organisms possess close homologs, all of which 
have a similar metal binding motif and an aliphatic repeat region of diverse length.   
 
1.3.3. Other Organisms Possessing Similar “Dimerization Domains” 
 Generally, CopY belongs to the penicillinase superfamily of bacterial repressors 
such as the popular β-lactamase repressor used commonly in the biomedical research 
field to enforce antibiotic resistance in host recombinant bacteria15, 35.  More specifically, 
CopY belongs to the BlaI/MecI family of transcriptional repressors based upon sequence 
similarity36-38.  However, functionally, CopY coincides with the ArsR/SmtB family of 
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metal-sensing repressor proteins.  Such a repressor from E. faecalis shares 94% amino 
acid homology (84% identity) to CopY, making it CopY’s closest ancestor.   
The CopY protein can be found in other organisms using the Basic Local 
Alignment Search Tool (BLAST) from the National Center for Biotechnology 
Information (NCBI)39.  The majority of proteins which share greater than 50% homology 
with CopY are located within the gram-positive division of the firmicutes bacterial 
phylum.  Such bacterial species possessing similar whole CopY repressors with cysteine-
rich metal-binding sites are Enterococcus faecalis, Lactobacillus actei, Streptococcus 
pyogenes, Streptococcus alagactiae, Streptococcus thermophilus and Streptococcus suis.  
Some of these species are not harmful (e.g. S. thermophilus), whereas a number of others 
(e.g. E. hirae, E. faecalis, S. suis, S. agalactiae, S. pyogenes) are pathogenic.   
Homologs of CopY’s C-terminal metal binding site can be found across a wide 
range of proteins from various species.  The –CxCx4CxC- motif is observed in many 
different protein classifications such as transporters, heat shock proteins, interleukin 
variants and GTPase activators according to NCBI’s BLAST program.  As a result, 
hundreds of proteins result from a search of only the CopY metal-binding site.  An 
expanded search including an aliphatic-repeat region adjacent to the metal-binding site 
produced more detailed results that include proteins that share common functionality.  
One surprising result included the human glutamate decarboxylase 2 enzyme that 
contains an N-terminal –CxCx4-5CxC- and an adjacent aliphatic-repeat region40.  Its 
crystal structure (PDB ID: 2OKK) does not provide any structural detail of the –
CxCxxxxCxC- site since it was removed from its gene sequence prior to purifying and 
crystallizing the enzyme.  Initial attempts at crystallizing the full-length enzyme produced 
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poor X-ray crystallographic resolution within its N-terminus, therefore its first 88 
residues were removed40.   
Investigation into GAD2’s ability to bind Zn(II) and create dimers in vitro 
commenced upon acquisition of the bacterial plasmid containing the full-length GAD2 
sequence including the cysteine motif.  Preliminary tests on the whole enzyme 
undertaken in the Dameron laboratory showed inhibition of its activity with the addition 
of Zn(II) to the assay (unpublished observations).  Analysis of the enzyme’s ability to 
dimerize is currently being done in an effort to show the metal-binding site and its 
adjacent aliphatic-repeat produce specific protein-protein interactions across protein type 
and phyla. 
 
1.4. Other Analogous Metal-Sensory Proteins 
 Based upon its structural topology, CopY belongs to the penicillinase-based 
BlaI/MecI/CopY family of winged-helix repressors34, 35, 37.  Winged helix proteins 
possess a characteristic helix-turn-helix DNA binding motif that interacts with the major 
groove of DNA, allowing repressors within the family to control gene expression34.  
CopY belongs to the penicillinase family of repressors based strongly upon its primary 
structural high homology to BlaI and other members41.  However, CopY’s functionality 
relies on its ability to sense high levels of Cu(I) within E. hirae, making it functionally 
similar to other metal-sensing repressors within the SmtB/ArsR family of proteins.  
Specifically, metal-derepressors found within many pathogenic bacteria such as 
Mycobacterium tuberculosis, Bacillus subtilis, and cyanobacteria contain metal-sensory 
abilities42, 43.  Often times within the family of repressors, the metal-binding sites reside 
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within the interface of the homodimer where bridging ligands originate from each half of 
the dimer44.  Metal detoxification systems for Zn(II), Cu(I), Ni(II), Pb(II), Co(II), Cd(II), 
As(II) and Fe(II) depend on metal-responsive homodimers in order to control the 
biosynthesis of proteins related to their metabolism36, 45, 46. 
 Metal derepression is the most common form of transcriptional factor control of 
the production of metal detoxifying proteins 36, 45.  Metal derepression utilizes metal-
binding to up-regulate the production of extrusion proteins in order to detoxify the cell36, 
45
.  Typically, these systems require the controlling repressor to bind the 
operator/promoter sequence of the downstream genes in order to inhibit protein 
biosynthesis36, 45.  Once induced through metal-binding at high concentrations, the cell 
regains homeostasis through the efflux of excessive metal36, 45.  Repressors retaining this 
functionality include ArsR, SmtB, CsoR and CopY42, 44, 47.  Conversely, metal co-
repressors down-regulate the uptake and import of metal ions within the cell.  Repressor 
proteins fitting this description include Fur, NikR and DtxR36, 45.  Examples of both 
metal-derepressors and metal co-repressors will be reviewed to highlight those 
characteristics similar to CopY in protein structure, metal-binding and dimerization.   
 
  
1.4.1. The Cadmium(II) Responsive Repressor CadC 
 The Staphylococcus aureus CadC protein is a metal-inducible repressor 
responsible for the detoxification of Pb(II), Cd(II) and Zn(II)17, 48.  Binding of any one of 
the aforementioned metals to CadC activates a membrane-spanning efflux pump to 
remove excessive concentrations of the metal17, 48.  Generally, CadC acts as a heavy-
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metal sensor for the cell when the presence of toxic metals becomes too great, the 
negative transcriptional regulator will dissociate from the cadCA operon to produce the 
CadA P-type metal-extrusion ATPase17.  In its repressed DNA-bound state, CadC binds 
across the cadC/A operator/promoter region in its apo form, contrary to CopY which is a 
Zn(II)-requiring repressor.  Once CadC is derepressed, the expression of CadA confers 
resistance to either excess Cd(II), Zn(II) or Pb(II) and facilitates its removal.   
 There are several noteworthy similarities between CadC and CopY.  For example, 
both repressor proteins belong to the winged-helix/helix-turn-helix family of repressors 
which contribute to each protein’s DNA-repressive capabilities48.  Also, both proteins are 
found in gram-positive bacteria.  Most importantly, CadC and CopY both possess a 
cysteine-rich, metal binding site inducible through the coordination of either Cu(I) for 
CopY, or Pb(II), Cd(II) or Zn(II) for CadC9, 17, 48.   
 Being a symmetrical dimer, each CadC monomer possesses two metal-binding 
sites, one regulatory site composed of all cysteines and its non-regulatory site constructed 
of residues from both monomers across its dimer interface9,49, 50.  The details of CadC’s 
dimerization are found in Figure 1.1.  Its regulatory site which binds Cd(II) and Zn(II) is 
reliant upon Cys7, Cys58, Cys60 and the Cys11 residue, which is not obligatory49, 50.  Its 
non-regulatory site, found to bind Zn(II) and Co(II), is not critical towards homodimer  
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Figure 1.1. Crystal Structure of the CadC Repressor (1U2W). 
The metal-responsive, homodimeric CadC repressor is depicted in ribbon format9.  
Each subunit is represented by either green or purple.  Zinc is indicated by blue 
spheres.  When crystallized and solved, its asymmetric unit included four subunits, or 
two separate dimers.  Shown above is the doubly-metallated Zn(II) dimer in Panel A.  
Hydrophobic interactions account for the majority of the stability where the 
coordinated Zn(II) at opposite ends of the α3/α5 helix might increase dimer affinity, 
as indicated in the top panel structure.  The two Zn(II) cations are bound to the non-
regulatory sites of the dimer.  Panel B depicts the metalated dimer in Panel A rotated 
by 90°, where the bottom surface of the dimer would bind DNA within the major 
groove.   
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binding with subsequent preservation of dimerization, to the bond distances between 
thiolate ligands and coordinate metals, CopY and CadC both share similar global folds 
and functions, along with intracellular mechanisms that efficiently control Cu(I) and 
Cd(II), respectively. 
 
1.4.2. The Zinc-Responsive Homodimer SmtB 
 Originating from a Synechococcus PCC7942 plasmid composed of transition 
metal resistance genes, the SmtB protein is a trans-acting metallothonein repressor that 
binds Zn(II) and Cd(II)47, 51.  SmtB’s α + β topology produces a classic helix-turn-helix 
motif, similar to the aforementioned CadC and this project’s target CopY repressor52.  
Based on homology, SmtB has also been placed in a family of winged-helix, metallo-
regulatory repressors with CadC and the arsenic-resistance repressor ArsR from 
Escherichia coli52.  Consequently, SmtB does not adapt a metallated form like CopY 
while in its nucleic-acid bound form, but remains apo until activated by an influx of 
Zn(II)43.  Figure 1.2 contains a structure of the apo-SmtB repressor. 
 Each subunit possesses one empty metal binding site positioned at the C-terminus, 
easily solvent accessible to bind metal44, 45.  Similar to CadC, in its dimeric DNA-bound 
form, two additional sites are created at the interface of dimerization51.  Upon activation 
of SmtB, the influx of Zn(II) binds and derepresses the operon, signaling for its release 
from the cell36.  Unlike CadC, SmtB’s regulatory site is pointed away from the dimer 
interface36, 44.  Each SmtB monomer’s N-terminal metal-binding located on the α3 helix 
is not inductive, however the C-terminal α5 helix is responsible for repressor  
  
14 
 
Figure 1.2. Crystal Structure of the Zn(II)-Responsive SmtB Repressor (1SMT). 
The Zn(II) responsive metallothionein SmtB repressor from Synechococcus elongates 
rendered in Jmol53, 54.  Crystallized as an apo protein, the repressor is known to have a 
total of four Zn(II) binding sites between the two subunits; two at flanking ends of the 
dimer and two along the dimer interface.  SmtB is known to have homology to CopY 
through its shared helix-turn-helix DNA-binding motif.  It is predicted that CopY 
might possess a similar elongated structure.   
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stabilization, but may increase its affinity when metal is bound49.  It is composed of 
Asp101 and His103 from one monomer and His114 and Glu117 from the other, similar to 
other repressors from the ArsR/SmtB family17, 48, 49. From the perturbation of DNA  
induction16, 36, 44, 49.  Its close homolog ArsR contains an N-terminal regulatory site 
assignment, opposite compared to SmtB16, 44, 45. 
 CopY is a Zn(II) requiring Cu(I)-sensing repressor protein, where a motif of 
cysteines coordinate bound metal to its C-terminus.  Ligands responsible for Zn(II) 
coordination to SmtB are not exclusively cysteinyl in nature51, 52.  As in zinc finger 
repressors, a homo- or heterogeneous composition of ligands exists to bind Zn(II), which 
includes histidine, glutamic acid, aspartic acid or cysteine47. SmtB possesses an array of 
residues responsible for zinc sequestration47, 51.   Upon induction of an apo dimeric SmtB 
via excess Zn(II), the newly coordinated metal displaces the metallated dimer complex 
from the smtB/A promoter47, 51.  Like CopY, SmtB obeys similar mechanistics in terms of 
its ability to sense Zn(II) and activate its metabolism.  Contrarily, SmtB does not require 
a pre-existing metal to occupy its metal-binding sites as CopY requires Zn(II) before it 
can sense high Cu(I) levels43. 
 The sampling of ArsR/SmtB family members indicates CopY’s close similarity in 
terms of their ability to transfer the detection and coordination of metals into 
conformational changes within protein quaternary structure which allows the cell to 
maintain homeostatic equilibrium.  In addition, each regulatory binding site coordinates 
several different metal ions within the same location, albeit different geometry. The 
differences between CopY and the ArsR/SmtB family lie within the starting, repressive 
conformation of the regulating proteins, being predominantly apo prior to metal 
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induction.  Also, ArsR/SmtB repressors contain several binding sites, some produced 
through the fusion of subunits which have been studied to be non-regulatory in nature.  
The purpose of these metal-binding sites physiologically is largely unknown, but appears 
to be a trend seen in all repressors that belong to the ArsR/SmtB family. 
 
1.5. Significance Behind Metal-Controlled Dimerization 
 A small region of CopY’s dimer has been explored, but it is hypothesized that a 
larger sequence spanning multiple regions harbors its interaction strength.  However, 
other forces are hypothesized to contribute affinity to CopY’s dimer aside from the 
metal-binding site alone.  As a metal-sensory repressor protein, CopY’s C-terminus may 
be used in other scientific applications to bring normally monomeric proteins closer in 
proximity through dimerization.  The CopY sequence may possibly be used as a sensor or 
diagnostic tool because of its inherent structural changes when Zn(II) is displayed by 
Cu(I).  Being able to provide a relevant contribution towards detailing the dimerization 
properties of CopY’s C-terminus may lead its use towards a broader area of science.  
Therefore, the characterization of a new dimerization tag can certainly have a dynamic 
impact upon the field of protein-protein interactions research. 
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1.6. Hypothesis and Specific Aims of this Research Project 
 
 It is hypothesized that both CopY’s metal binding site and 
aliphatic repeat contribute to the formation of dimers. 
 
I. Dissect the thermodynamics of CopY’s dimerization domain. 
 CopY’s dimerization domain will be fused to normally monomeric proteins to 
establish its use as a dimerization tag.  Therefore, through molecular biology, the gene 
sequence for CopY’s C-terminus will be isolated from whole CopY and modified in 
order to investigate the regions critical to the interaction.  Its modification will involve 
key deletions within its sequence that will further delineate which portions of the domain 
are most important towards preserving dimerization. 
 
II. Characterize a series of CopY deletion mutants for their ability to 
form stable homo- and hetero- dimers in vivo. 
 Many combinations of mutations and deletions can be created within the CDG 
sequence, but the ideal outcome is to assess if the cell can produce both homo- and 
hetero-dimers in vivo.  Fortunately, methods exist which allow for the indirect monitoring 
of dimerization within the cell.   
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1.7. Techniques Employed to Address Specific Aims 
 Many methodological approaches exist that are successful in studying the 
dimerization of proteins, both in vivo and in vitro.  The research presented in this thesis 
was completed using two independent techniques that allowed for the analysis of the 
formation, construction and composition of the metal-induced dimerizing C-terminus of 
CopY.  Isothermal titration calorimetry (ITC), an in vitro biophysical technique was used 
to gain valuable thermodynamic results that describe the portions of CopY that contribute 
to the formation of stable dimers55.  Secondly, an in vivo technique referred to as protein-
fragment complementation assays, allowed for the same CopY constructs being tested 
with ITC, to be screened for their ability to form similar complexes within a live cellular 
environment56.  The assay also allows for the testing of both homo- and hetero-dimer 
formation to gain valuable information as to exactly how CopY’s C-terminus dimerizes. 
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Chapter 2 
 
Materials & Methods 
 
2.1. Materials 
 All materials utilized in this research were obtained of the highest grade or purity 
unless otherwise noted.  All chemicals were purchased through Fisher Scientific unless 
otherwise noted.  In addition, all liquid media, buffers and experimental solutions were 
prepared with 18-MΩ Milli-Q® deionized water and prepared according to the general 
principals presented in Molecular Cloning: A Laboratory Manual57.  The CloneManager 
Suite Version 6.00 software package (Sci. Ed. Central) was used for the visualization and 
analysis of all DNA sequences.  The BioEdit program was used to analyze DNA 
sequencing data58.  HIS-Tag affinity chromatography resin obtained from Sigma®.   
 
2.2. Media 
 Luria-Bertani (LB) broth was prepared in 5x stock concentrations and diluted to a 
1x working concentration upon culturing bacteria.  The 5x stock solutions comprised 50 g 
of tryptone, 25 g yeast extract, 25 g NaCl, 500 µL of 10M NaOH with the addition of 
Milli-Q® water to 1 L.  All media was autoclave-sterilized for 45 minutes at 121° C prior 
to use for the bacterial overexpression of recombinant DNA clones57.  SOC media was 
prepared similarly, made in one liter quantities following the recipe outlined previously57.  
Per liter, 20 g tryptone, 5 g yeast extract, 2 mL 5M NaCl, 2.5 mL 1M KCl, 10 mL 1M 
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MgCl2, 10 mL 1M MgSO4 and 20 mL of 1M glucose were combined with the addition of 
900 mM deionized, distilled water.  The mixture was autoclave- sterilized for 45 minutes 
at 121° C.  It was used exclusively in the heat-shock transformation of known DNA 
constructs and potential clones. 
 
2.3. Spectroscopic and Calorimetric Instrumentation 
 
2.3.1. Ultraviolet-Visible (UV-Vis) Spectroscopy 
 A Cary® 1E UV-Vis spectrophotometer was used throughout this research.  The 
UV-Vis was used for determining specific measurements such as plasmid DNA 
concentration, elution profiles of purified proteins and reduced cysteine content within 
proteins in solution. 
 
2.3.2. Isothermal Titration Calorimetry (ITC) 
 A MicroCal MCS ITC instrument was used for conducting all dimer dissociation 
experiments.  A circulating water bath coupled to the instrument enabled control of the 
experimental temperature.  Having the circulator set 5° C below the experimental 
temperature insured the instruments setting would not be exceeded.  All experiments 
were conducted at 25° C unless otherwise noted.  All protein samples were degassed for a 
minimum of 30 minutes with vigorous stirring at a temperature of 0.1° C below the 
experimental temperature. Each experiment was programmed for 30 injections of 8 µL/ 
injection and an injector stirring speed of 400 rpm.  The first injection was typically 2 µL 
and was usually ignored due to dilution effects from the injection syringe.  Injections 
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were spaced out to dispense every 200 seconds, allowing for the strong dimer-
dissociation signals to retain back towards baseline before the next injection took place.  
All protein samples were buffered in 50 mM Tris pH 7.8, 300 mM NaCl, and 0.01%(v/v) 
β-mercaptoethanol added fresh prior to use.  Data analysis of ITC experiments was done 
using MicroCal’s version of Origin 7.0 software coupled with several advanced fitting 
models including the dimer dissociation model.  The dimer dissociation calculation is 
programmed to fit single binding site model.  The final values determined by the fitting 
program produces a Kd and a ∆H for the entire reaction.  The ∆H value represents the 
total heat of the dimer dissociation reaction.  Origin software calculates the quantity by 
integrating the area between the raw spikes from the thermogram and the lower baseline 
between each peak.  Each determined value is an indicator towards the strength of the 
dimer, where large Kd values correlate with larger enthalpies. 
 Initial concentrations of titrant dimer began at 1 mM for all proteins tested (Figure 
2.1).  High protein concentrations would insure the final concentration of protein within 
the ITC cell would end sufficiently higher than the dissociation constant of the construct 
being tested.  Ideally, at the very end of an ITC experiment, with no dimer-to-monomer 
transitions occurring, one would expect the raw thermogram to produce basal energies 
signified only for the accommodation of more protein within the cell (Figure 2.2).   
 Dimer dissociation experimental data does not produce sigmoidally-based non-
linear fits like a ligand-macromolecule binding experiment would55.  Dimer dissociation 
experiments rely on the concentration-dependent gradient of dimer-to-monomer 
transitions that occur throughout the titration because of the constant amount of protein 
being injected within the cell.  As the concentration of protein within the cell increases, 
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approaching the dimer’s dissociation constant, progressively less dimer dissociation 
occurs.  As the experiment proceeds to the end, dimer from the syringe does not 
dissociate fully when entering the cell, but remains predominantly dimer as the 
concentration becomes markedly high within the cell.  The equilibrium is shifted towards 
the formation of dimers within the cell.  At the endpoint of the ITC experiment, the 
equilibrium state of the cell only detects the injection of concentrated dimeric protein 
within a cell of the same, producing small energy signals as a result of accommodating 
more protein.   
 ITC is heavily used to characterize the thermodynamics of macromolecule-ligand 
interactions, but has recently expanded its to include macromolecular interactions59.  The 
idea of studying the reversible homodimerization of proteins was first described by 
Velazquez-Campoy et al55.  Detection of dimer dissociation was done through observing 
the progressive titration of concentrated dimeric protein within an injection syringe, into 
an adiabatic cell containing an identical buffer to the dimeric protein (Figure 2.1).  At the 
onset of the reaction, the largest amount of dimer dissociation to monomer is observed, as 
indicated by the large, upward endothermic spikes in the thermograph.  As the titration 
progresses, a transition will occur where a decreasing amount of dimer dissociation 
occurs within the cell because the protein concentration surpasses the interaction’s 
dissociation constant.  At the end of the titration, little dissociation occurs according to 
the small set of spikes at the end of the thermograph.  By calculating the area underneath 
each spike which represents total energy from each dissociation injection, Velazquez-  
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Figure 2.1. Theory behind Dimer Dissociation using ITC. 
A schematic of the interior of an ITC cell and injection syringe is shown.  The 
syringe filled with dimeric protein (indicated by the letter D) placed within the 
calorimetric cell of an ITC unit.  As the experiment proceeds, monomer-dimer 
equilibrium is established after every injection is dispensed within the cell.  At the 
beginning of an experiment, equilibrium is shifted greatly towards monomer 
(indicated by M); as protein concentrations increase, the equilibrium gradually shifts 
more to dimer as the dissociation constant is surpassed. 
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Figure 2.2. ITC Data of the Reversible α-Chymotrypsin Dimer. 
Typical dimer-dissociation reaction data is shown conducted by Velazquez-Campoy et al55. 
Upper Panel: Concentrated dimeric protein is titrated into a stirred reaction cell of buffer.  
The raw spectrum depicts the change in heat versus time as the sequence of injections occurs.  
The upperward spikes indicate that the instrument supplies heat to the reaction cell because 
the temperature decreases upon the dissociation of dimer, representative of an endothermic 
reaction. The experiment was performed at 25°C. Lower Panel: Plot of the injection heat 
observed versus concentration of α-chymotrypsin in the reaction cell. As the concentration of 
protein increased within the reaction cell, a decrease in the dissociation of dimer is observed 
as the concentration of protein surpasses the Kd of the protein’s monomer/dimer equilibrium.  
The data obtained from this experiment agrees with previously reported analytical 
ultracentrifugation data of the same dimer dissociation model60. 
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Campoy et al. show that the total enthalpy of the reaction along with the reaction’s 
dissociation constant can be obtained55.   
 To facilitate the correct calculations when fitting all dimerization data, dilution 
effects were subtracted away from all experimental CDG data.  Usually buffer dilution 
effects are subtracted from experimental data through running separate control 
experiments of similar injection volumes of buffer into a cell filled with identical buffer.     
 
2.4. General Molecular Biology Methods 
2.4.1. Plasmid DNA Purification, Determination of Concentration and 
Purity 
 The principal method of purifying plasmid DNA from bacteria was through a kit-
based protocol produced by Promega®.  Their Wizard® Mini-Prep kit operates through 
the methodology derived from the well-known alkaline lysis method of plasmid DNA 
purification by precipitating cellular proteins, organelles and membranes while leaving 
plasmid DNA soluble in the lysate.  Preparation of plasmid DNA begins through 
harvesting 3-5 mL of a saturated bacterial cell culture containing a plasmid-of-interest via 
centrifugation (usually 5000 x g for 10 minutes using a 15- or 50-mL centrifuge tube).  
The LB broth was decanted from the cell pellet where 300 µL of a resuspension solution 
(50 mM Tris, pH 7.5, 10 mM EDTA, 100 µg/mL RNase A) is added to both resuspend 
the cell pellet and to degrade any RNA molecules that may bind or interfere with 
subsequent experiments involving the purified plasmid.  The suspension was transferred 
from the centrifuge tube to a 1.5 mL microcentrifuge tube.   
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 Next, the resuspended cells were lysed by adding an equal volume of 0.2 M 
NaOH and 1% SDS to the prep.  The tube was capped and inverted gently several times 
to mix the solution.  The addition of 300 µL 1.32 M potassium acetate, pH 4.8 will 
precipitate cellular debris and most protein into a white precipitate upon capping the tube 
and inverting the prep several times without vortexing.  By centrifuging the preps at 
10,000 x g for 8 minutes in a microcentrifuge tube, all cellular debris was pelleted 
allowing one to separate the desired soluble plasmid DNA from the precipitate.  The 
lysate can then be applied to 1 mL of a silica-based Wizard® DNA Purification resin.  
The mixture of lysate and resin is placed within a 3 mL syringe attached to a mini-
column via a luer-lok.  The addition of 2 mL of 80 mM potassium acetate, 8.3 mM Tris, 
pH 7.5, 40 µM EDTA, 55% ethanol after the lysate/resin mixture was passed through the 
mini-column will aid in washing the resin.  Elution of the plasmid DNA was done using 
sterilized water or TE buffer. 
 Analysis of the purity and concentration of plasmid DNA preps was completed 
spectrophotometrically.  At a wavelength of 260 nm, the base-stacking of double-
stranded DNA absorbs light, so one is able to directly determine concentration in ng/µL.  
Fifty µg/mL of plasmid DNA produces an A260 of 1.00, therefore measuring the 
absorbance of a purified prep allows one to determine concentration.  In addition, purity 
of a plasmid prep can be assessed through measuring the A260/A280 ratio using a UV-Vis 
spectrophotometer.  The ratio indicates the relative amount of plasmid DNA versus the 
amount of protein within a preparation.  Ratios of 1.60-1.80 indicate high plasmid purity. 
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2.4.2. Preparation of Competent Cells 
 The following E. coli strains were obtained from Stratagene®: BL21, XL-1 Blue.  
The following E. coli strain was obtained from Novagen®: Rosetta2(DE3).  BL21 cells, 
along with XL-1 Blue cells were used as a general cloning host throughout steps where 
cloning methods were to be completed.  Rosetta2(DE3) cell lines were used for 
completed plasmid constructs to overexpress protein in which they encode when grown.  
XL-1 Blue (Stratagene) competent cells were used in mutagenesis experiments because 
their transformation efficiency was higher than that of the BL21 cells. 
 Chemically competent cells were made using the Rubidium chloride method57.  
Rubidium-chloride competent cell preparation was applied for the entire array of cell 
lines used with the exception of XL-1 Blue “Supercompetent” cells (Stratagene).  
Preparation begins by culturing the desired cell line in 2 mL 1x LB media overnight.  The 
saturated culture was used as 1% innoculant for a larger 200 mL culture was grown at 37° 
C until the OD600 reaches 0.4.  The cells were then harvested by centrifugation at 5000 x 
g for 10 minutes.  The cell pellet was decanted and resuspended with 80 mL filtered, ice-
cold 30 mM potassium acetate, pH 5.8, 10 mM rubidium chloride, 10 mM calcium 
chloride • 2H2O, 50 mM manganese chloride, 15% (v/v) glycerol.  The suspension was 
placed on ice for one hour upon which the suspension was harvested via centrifugation at 
5000 x g for 10 minutes.  The cell pellet was decanted and resuspended with 8 mL 
filtered, ice-cold 10 mM MOPS, pH 6.5, 75 mM calcium chloride, 10 mM rubidium 
chloride, 15% (v/v) glycerol.  The suspension was left on ice for 2-6 hours.  The 
competent cells were aliquotted, either by 20 µL per 600 µL microfuge tube for 
immediate use, or by 1 mL aliquots stored in 1.5 mL microcentrifuge tubes to be re-
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aliquotted later.  Aliquotted cells were kept on ice until the competent cells were “quick-
frozen” using a -78° C bath with dry ice and either methanol, ethanol or isopropanol.  
Upon quick-freezing, all aliquots were placed in a -70° C freezer until used. 
 
 
 
2.4.3. Transformation of Competent Cells 
 The procedure for transforming competent cells was undertaken utilizing the 
specifications from each cell strain’s vendor and not according to the protocol provided 
with the rubidium-chloride method of achieving chemical competency.  The most 
important specification to follow in transforming competent bacteria is to “heat shock” 
each reaction at the specific temperature and time interval outlined by the vendor.  For 
Novagen competent cells such as Rosetta 2 (DE3) cells, a 30-second heat-shock was 
performed at 42° C whereas Stratagene recommends the same temperature but at a 
longer, 45-second interval.   
 Each transformation began by transferring frozen aliquots of competent cells 
directly to ice from the freezer.  Each aliquot was handled by avoiding touching the body 
of each microfuge tube containing an aliquot of competent cells and to handle them by 
touching the tube top.  One microliter of plasmid was transferred to each transformation 
reaction and let incubate for a minimum of 5 minutes, but for no longer than 30 minutes.  
At which time, heat-shock was facilitated by programming a PCR machine soak file for a 
constant 42° C.  Immediately after the heat shock step, each reaction was transferred back 
to ice for a minimum 2 minutes before the addition of 100 µL of SOC media.  SOC 
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media is usually provided by the vendor but can be readily prepared and autoclaved.  The 
reaction was then transferred to a shaking incubator set to 37° C and 250 rpm for 30-60 
minutes.  After incubation, each reaction was plated on 1x LB agar plates containing the 
necessary selectable markers.  Once the reactions were plated and all excess liquid has 
been absorbed into the media, the plates were inverted and placed into a standing 37° C 
incubator.  Incubation times varied consistent with the strain of bacteria used.  All BL21-
derived E. coli strains usually took between 12-16 hours to produce colonies, whereas 
strains such as XL-1 Blue take at least 18 hours to produce colonies. 
 
2.4.4. DNA Sequencing 
 All clones produced through the duration of this research project were verified via 
DNA Sequencing of all resultant plasmid DNA constructs.  The core facilities at the 
University of Pittsburgh Department of Genetics and Proteomics are responsible for the 
operation of the sequencing core facility.  The core facility utilizes an automated 
dideoxy-based Sanger method of DNA sequencing where they charge a base fee per 
sequencing reaction61. 
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2.5. PCR-Based Molecular Biology Methods 
2.5.1. PCR Amplification of Target Genes and Topoisomerase-Based 
Cloning 
 All thermo-stable DNA polymerase enzymes used were derived from Pyrococcus 
furiosis.  These polymerases, named “Pfu” polymerases, contain a C-terminal 
proofreading domain which insures that the genes being amplified are correct and that 
mutations associated with “Taq” based polymerases derived from Thermus aquaticus are 
eliminated.  In addition, Pfu-based enzymes do not leave a single adenosine overhang at 
the end of a PCR product where Taq-based enzymes do.   
 All PCR reactions were carried out using a PerkinElmer® Cetus Thermo Cycler 
and all PCR primers were synthesized by Operon Biotechnologies®.  All gene sequences 
were amplified using either Pfu DNA Polymerase (Stratagene) or Platinum® Taq DNA 
Polymerase (Invitrogen).  PCR products produced were either primarily in the restriction 
digestion and subsequent ligation into a desired vector that had been digested with 
enzymes producing similar “sticky” ends.  Contrarily, other PCR reactions were directly 
cloned into a topoisomerase-based cloning system called TOPO cloning.  The pCR 
TOPO 2.1 Cloning Kit (Invitrogen®) is a kit-based method of cloning PCR products 
directly into a linearized plasmid where the cloning is facilitated by a topoisomerase 
enzyme conjugated to the ends of the vector.  Topoisomerase-based subcloning allowed 
for the insertion of sequences into an intermediate vector instead of attempting low yield 
restriction digestion of PCR products where the restriction sites were close to the end of a 
DNA fragment.  Hence, cloning a gene into an intermediate vector provided plenty of 
sequence flanking an insert-of-interest so restriction enzymes could bind their recognition 
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sites with higher efficiency.  The cloned inserts are restriction digested and able to be 
cloned into a final desired vector cut with similar enzymes. 
 
2.5.2. Site-Directed Mutagenesis 
 All site-directed mutagenesis experiments were performed using either the 
QuikChange® Site-Directed Mutagenesis Kit (Stratagene®) or the Phusion® Site-
Directed Mutagenesis Kit (Finnzymes/New England BioLabs ®).  Pairs of degenerate 
primers were designed with the help of the Clone Manager® (Scientific Education 
Software) software program.  Each set of primers consisted of one “forward” primer 
proceeding in the 5’ 3’ direction whereas the other primer binds to plasmid DNA in the 
opposite orientation.  Regardless, each primer contained the desired base pair mutation(s) 
that would produce the final clone.  To help in the screening process for positive clones, a 
restriction enzyme addition or deletion was often used in designing mutagenesis primers 
where positive mutants could be screened by restriction mapping.  All positive mutants 
were confirmed by DNA sequencing.   
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2.6. Plasmid DNA Constructs 
2.6.1. CopY Dimerization Gene (CDG) 
 CopY possesses very high hydrophobicity, consequently making it poorly soluble 
when expressed in vitro.  To facilitate the isolation of large quantities for studies 
requiring upper micromolar to low millimolar concentrations of protein, an alternative 
DNA construct containing CopY’s dimerization domain was necessary.  As previously 
described, the CopY gene can be dissected into two putative domains: its N-terminal 
DNA binding domain comprised of residues 1-61, and its “dimerization” domain which 
includes residues 62-14515, 19.  Based upon secondary structural predictions (Figure 2.3), 
the aliphatic-repeat N-terminally adjacent to the metal-binding site produces three alpha-
helices62, 63.  Because of its amphipathic nature, a two-stranded coiled-coil motif is 
predicted with high probability spanning Helices 2 & 3 according to the COILS 
prediction program (Figure 2.4)64.  With these findings, the aliphatic-repeat will be 
treated in a manner where each alpha helix will be studied to determine which support 
dimer formation.  
 Given the limitations outlined above regarding full-length CopY’s solubility, a 
synthetic gene was created.   A modified CopY was engineered utilizing only its C-
terminus with restriction-enzyme sets between alpha helices.  The engineered construct 
allowed for whole alpha helices to be deleted within the aliphatic repeat (AR).  The new 
construct, termed “CDG”, will provide large quantities of soluble protein in order to 
address the specific aims of this research.  As part of its design, CDG was separated from 
the DNA binding domain and cloned separately as its own gene construct composed of 
the aliphatic-repeat and the metal-binding site (MBS.).   
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Figure 2.3. Secondary Structural Prediction Output for CDG’s Dimerization 
Domain (Residues 61-145). 
The particular prediction program used was entitled the Advanced Protein Secondary 
Structural Prediction Server, or “APSSP262, 63.”  The primary sequence for CopY was 
obtained from the National Center for Biotechnology Information (NCBI) website 
where the sequence from residue 61-145 was queried and the results are shown 
above.  Its sequence was altered to match that of CDG and then input into the 
PSIPRED program.  Green cylinders represent alpha helices (“H”), where three are 
predicted within CDG’s aliphatic repeat and can be labeled from N- to C-terminus, 1, 
2, and 3.  Predicted random coil is indicated by “C” and beta-sheet is shown to be a 
yellow arrow, or “E.” High probability of an accurate prediction is indicated by the 
size of the “Conf” bars above the primary sequence.   
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Figure 2.4. Quaternary Structural Prediction of CDG using the COILS Prediction 
Server. 
Using the 28-residue search window, the CDG primary sequence was queried using 
the COILS server to predict coiled-coil formation64.  The x-axis represents the length 
of the sequence queried while the y-axis indicates probability. According to the 
output above, there is greater than a 95% probability of coiled-coil formation from 
residues 42-69 (residues 103-130 of full-length CopY). 
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 The pET19b (Novagen®) inducible bacterial vector was selected to house the 
CDG synthetic sequence (Figure 2.5).  It contains a 10x HIS-Tag that is Enterokinase-
cleavable.  It also contains three cloning sites that allow for the cloning of genes that 
encode for fusion proteins that will solubilize the CDG sequence.  Lastly, its expression 
system is controlled by the T7-lac promoter which is a powerful protein expression 
system when protein production is induced through the addition of isopropyl β-D 
thiogalactopyranoside (IPTG). 
 While preserving amino acid composition, three pairs of restriction enzyme 
recognition sites; SnaBI, BsrGI and SalI were engineered within the aliphatic region of 
CDG.  The spacing of each pair aims to delete portions of the beginning, middle, and end 
of the aliphatic region based upon CopY’s secondary structural prediction (Figure 2.3), 
where the sequence closest to the metal-binding site is located at the end of the aliphatic 
repeat (A.R.).  Therefore, it is hypothesized that the aliphatic region closest to the metal-
binding site is more critical towards stabilizing dimerization rather than portions less 
proximal to it. 
 The additional restriction sites were engineered in a way that preserves the 
domain’s amino acid identity by using a different codon for the same amino acid (Figure 
2.6).  To avoid problems with codon-bias for bacterial protein expression because of the 
changes, all large-scale protein preparations utilizing the CDG sequence were cultured 
using Rosetta 2(DE3) expression cells (Novagen®) which possess an extra plasmid 
which contains the genes for seven rare tRNA codons.  In addition, XhoI and SalI sites 
flank the CDG’s aliphatic repeat which allows for the removal of the entire aliphatic 
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Figure 2.5. Circular CopY Dimerization Gene (pCDG) Vector. 
Depicted above is a representation of the vector coding for N-10xHIS-rEK-Flexible 
Linker-C.  The CDG gene construct was purchased from BioBasic, Inc.  The “Amp” 
element indicates the gene for beta-lactamase which provides bacterial resistance in 
the presence of ampicillin.  The bacterial origin of replication is represented by 
“pBR322 Ori.”  The synthetic gene was subcloned into a pET19b vector (Novagen®) 
within the XhoI and BamHI sites.  In order to attach a fusion tag to this construct, the 
NdeI and XhoI pair of restriction sites would provide an in-frame fusion linkage. 
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CopY  61-ALWTEQEGKKFIYHPAVSEMENVRSATENLFSHICAKRVGATIAD-103  
CDG    1-ALWTEQQGKKFTYHPAVSEMENVRSATENLFSHICVQRVGATIAD- 42  
 
 
CopY  104-LVEEATLTQEDVQQIMKQLNKKEPVETIECNCIPGQCECKKQ-145 
CDG    43-LVDEATLTQEDIQQIMKQLNKKEPVETIECNCIPGQCECKKQ- 84 
 
Figure 2.6. CDG DNA Sequence and Alignment of CopY and CDG’s Primary 
Sequences. 
The engineering of the CDG sequence produced a highly homologous sequence, 
limiting drastic changes in CDG’s designed primary sequence.  The three predicted 
alpha helices are underlined.  All changes in primary sequence are highlighted in 
yellow.  CDG is 94% identical in primary sequence to CDG and contains 98% 
homology based upon the replacement of similar amino acids.  CopY’s sequence 
begins at residue 61 and continues through the remainder of the protein. 
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region to assess the dimerization of the metal-binding site.  XhoI and SalI when used in 
cloning, produce the same cohesive ends, allowing the vector to be ligated back together.  
Contributions of the metal-binding site alone can be completed by removing it and testing 
the remaining CDG sequence.  A single-nucleotide site-directed mutation before the first 
cysteine in the metal-binding site will produce a STOP codon, creating a protein 
construct that only comprises the aliphatic-repeat, effectively removing the metal-binding 
site from the remaining CDG construct. 
 Figure 2.6 displays CopY’s primary amino acid sequence.  It also displays the 
CDG sequence and its overall similarity in amino acid composition to CopY after 
engineering the three pairs of restriction enzyme sites.  Figure 2.7 outlines in a schematic 
representation, the many combinations of metal-binding site mutants linked to aliphatic-
repeat deletions.  The “SnaBI” restriction enzyme pair (Figure 2.7, dark blue box) 
provides the ability to cut out the following CDG sequence in the beginning of the 
aliphatic region: YALWTEQQGKKFTY where underlined sequence denotes secondary 
structural prediction of alpha helical sequence.  The middle aliphatic deletion is 
facilitated through restriction enzyme cutting by BsrGI (Figure 2.7, middle, teal box).  It 
removes 21 amino acids: VQRVGATIADLVDEATLTQED.  The final aliphatic deletion 
is produced through restriction digestion with SalI (Figure 2.7, right side, light teal box) 
which removes the following 23 amino acids: VDEATLTQEDVQQIMKQLNKKEP.  
Each one of these constructs can be produced without a metal-binding site if desired.  
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                                                                                                         Metal Binding 
                                                                                                                 Site 
 
Figure 2.7. CDG Protein Constructs of Aliphatic-Repeat Deletions with and without 
a Metal-Binding Site. 
The color-coordination represents the CopY dimerization domain where each shade 
of blue represents a predicted alpha helix that can be removed using molecular 
biological methods.  Each of its three alpha helices is numbered in order as they 
appear within the sequence.  CDG provides the ability for removal of one alpha helix 
at-a-time using molecular biological techniques.  Pictured in red is the cysteine-rich 
metal-binding site.  Also shown are all the combinations of CDG constructs with 
mixtures of aliphatic-repeat deletions with and without an adjoining metal-binding 
site. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Possible Constructs                                        Possible Constructs                    
Without MBS                                                   With MBS 
 1.                                2.                               3. 
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2.6.2. Fusion of CDG to a Solubility-Enhancement Tag (SET) 
 Initial expression tests of the CDG sequence encountered poor protein production.  
Since CDG’s hydrophobicity was high, the genetic fusion of a solubility-enhancing tag 
was required65.  The possibility of using a small, highly structured fusion protein was 
explored, such as the immunoglobulin binding domain of the streptococcal protein G, or 
GB166.  A larger protein such as maltose-binding protein (MBP) can be used for 
biophysical dimerization studies because the size differences between monomer and 
dimer are more pronounced than with a smaller fusion67.  Upon testing the 
overexpression and purification of both GB1-CDG and MBP-CDG, maltose-binding 
protein (MBP) was selected because initial expression and purification results showed its 
purity and overall yield to be greater.  Furthermore, the MBP-CDG construct appeared to 
be more suitable for ITC studies.  A plasmid containing the gene sequence for MBP, 
malE was purchased from New England BioLabs®.  The subcloning of the malE gene 
into the CDG plasmid was completed using flanking NdeI and XhoI sites. (Figure 2.8 and 
Figure 2.9).   
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Figure 2.8. malE-CDG Bacterial Plasmid Construct (pMBP-CDG). 
A schematic diagram showing the synthetic CDG sequence fused with the malE gene 
which encodes MBP.  The malE- CDG fusion construct is pictured subcloned within 
the pET19b bacterial expression vector (Novagen®).  MalE was cloned using NdeI 
and XhoI restriction enzymes to create an in-frame construct with CDG. 
 
 
 
 
 
42 
 
Figure 2.9. Scaled Schematic Representation of malE-CDG Construct. 
The fusion of the maltose-binding protein gene, malE, to the synthetic CDG sequence 
is depicted above.  Within the aliphatic-repeat are the three pairs of restriction digest 
sites used to probe each predicted alpha helix and its possible dimeric character.  The 
translated product of this construct produces a 520 amino-acid protein with a mass of 
57.3 kDa. 
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2.7. Protein-Fragment Complementation Assays 
Protein-fragment complementation relies on the re-construction of two halves of a 
reporter enzyme that were originally separated and cloned as a fusion to dimerizing 
sequences56, 68-71.  The in vivo complementation technique only operates on the premise 
of specific dimer formation since the refolding of any higher ordered structures will not 
reconstitute an active reporter enzyme that is critical for cell survival and assay viability.  
Typically, the assay is run like a two-hybrid assay, where cloned as a fusion to one 
enzyme half is an independent dimerizing sequence that remains nascent and unchanged.  
On the complementary enzyme half, you would clone as a fusion, various test sequences 
or mutations of the original dimerizing sequence in order to test for the formation of 
functional two-stranded dimers.   
 A bacterial-hosted assay, a mouse-derived dihydrofolate reductase (mDHFR) 
enzyme is used as the reporter (Figure 2.10).  Used within the agar of the bacterial M9-
based assay plates is a drug 5-(3,4,5- trimethoxybenzyl) pyrimidine- 2,4- diamine, or 
more commonly, trimethoprim.  It is a competitive inhibitor of bacterial dihydrofolate 
reductase (bDHFR) that has approximately 10,000-fold higher affinity for it rather than 
the mouse homolog.  Therefore, the production of mDHFR is reliant upon covalently-
linked protein-protein interacters to each of its two domains (Figure 2.11).  Dihydrofolate 
reductase is directly responsible for the reduction of dihydrofolic acid to tetrahydrofolic 
acid, which is used in the biosynthesis of thymidine phosphates.  Such precursor 
molecules made by the cell serve as building blocks for the creation of nucleic acids, 
specifically DNA.  Inhibition of the bacterial reductase enzyme would eliminate a cells 
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Figure 2.10. Three-Dimensional Structure of the murine Dihydrofolate Reductase 
Enzyme (mDHFR), PDB ID 2FZJ. 
Rendered in JMol is the mDHFR enzyme in ribbon format with bound NADPH and a 
derivative of trimethoprim in ball-and-stick format53, 72. The 5-(omega-
carboxy(alkyloxy) derivatives of trimethoprim bind mDHFR with greater than 5,000-
fold higher affinity than standard trimethoprim.  Trimethoprim is the acting inhibitor 
used in protein-fragment complementation56, 71.   
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survivability unless the mouse reductase is reconstituted through the dimerization of 
attached protein sequences. 
 Since expression of these recombinant fusion proteins is IPTG-inducible, a 
dimerizing pair will bring each linked enzyme domain within close proximity so re-
folding of the active DHFR enzyme occurs.  The refolded mDHFR enzyme directed 
through the dimerization of linked CDG sequences effectively supplants irreversibly 
inhibited bDHFR, allowing the host bacteria to survive and form colonies.  As an internal 
control, it has been specifically shown that a PFC assay setup involving only the two 
enzyme halves without any linked interacting sequences, or dimerizers, will not survive56, 
68, 73
.   
 Since bDHFR is an enzyme necessary for bacterial survival and within the 
complementation assay it is inhibited, the cells rely upon reconsituted mDHFR via 
dimerization.  Positive growth on each plate is indicative of the latter, creating a facile 
method of indirectly testing and observing specific two-stranded protein-protein 
interactions within live cells  A visual representation of the assay dynamics can be seen 
in Figure 2.11. 
 Two vectors, each containing either mDHFR[1,2]-Zip or mDHFR[3]-ZIP were 
obtained from Dr. Stephen Michnick’s laboratory at the University of Montreal, Quebec, 
Canada.  The vector designations signify that the gene sequences for domains 1 and 2 of 
mDHFR are cloned on one plasmid and the gene sequence for domain 3 of mDHFR is 
located on the complementary plasmid.  The rationale for dissection in this manner was 
conducted based upon analysis of the full-length enzyme’s crystal structure (PDB: 
2FZJ)72.  The CDG sequence was fused to each of the two DHFR enzyme-fragments 
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using restriction digestion with NdeI and XhoI.  Subcloning was done by BioPioneer (San 
Diego, CA).  Completion of each assay utilized competent Rosetta2(DE3) cells 
(Novagen).  The addition of 100 ng per vector was made to each competent cell aliquot 
on ice.  After heat shock at 42°C for 30 seconds, cells were transferred back to ice, 
followed by the addition of 200 µL SOC media.  Each assay mixture was incubated at 
37°C for 60 minutes in an orbital shaker.  After incubation, each assay mixture was 
centrifuged for 15 minutes, followed by a resuspension/wash step with ice cold 1 x PBS.  
Resuspended cells were then centrifuged again and then the process repeated an 
additional two times before plating.  The plate media recipe is as follows: 0.4% glucose, 
2 mM MgSO4, 0.1 mM CaCl2, 800 µg/mL casamino acids, 10 µg/mL thiamine, 1.2 mM 
IPTG, 100 µg/mL ampicillin, 25 µg/mL chloramphenicol and 1.0 µg/mL trimethoprim56.  
Completed assay plates were allowed to incubate at 30°C for 48 hours.   
 First, 8 g of agar and a small stir bar were placed within a one-liter bottle filled 
with 400 mL of deionized water and sterilized for 45 minutes followed by 30 minutes of 
slow exhaust.  After sterilization, the autoclaved bottle was placed on a stir plate while all 
added nutrients, casamino acids, and antibiotics were dispensed into a sterile 100 mL 
graduated cylinder.  The mixture of additives was brought to 100 mL total volume with 
sterile 1 x M9 Salts.  Upon cooling of the autoclaved agar to below 50° C, the 100 mL of 
additives was added slowly, pouring down the side of the bottle avoiding the addition of 
air bubbles.  Once added, assay plates were poured and allowed to cool and solidify for 2 
hours.  Assay plates were stored at 4° C and typically used within a one to two week 
timeframe.  
47 
 Concentrations of IPTG, additional ZnSO4 and trimethoprim were determined 
empirically.  A matrix of plate recipes varied in the concentrations of all the latter 
components was conducted on the DHFR[1,2] CDG/DHFR[3] CDG complementation.  
Concentrations of IPTG ranged from 0.1, 0.2, 0.5, 1.0, 1.2, 1.5 and 2.0 mM; Zn(II) 
ranged from 0.5, 1.0, 1.5 and 2.0 mM and trimethoprim ranged from 1.0, 1.5, 2.0, 5.0 and 
10.0.  Quantities of each of the three different additives were added directly to the plate 
before pouring.  The remaining components including other antibiotics, salts and 
casamino acids were prepared as already described.  Upon cooling of the agar, the 
salt/amino acid/antibiotic mixture was added to the autoclaved agar.  The mixture was 
then poured into the plates already containing the varied amounts of trimethoprim, ZnSO4 
and IPTG.  The preparation of plates, in addition to all transformations was completed at 
one time.  The varied mixture that produced the optimum amount of colony growth (225 
colonies) upon the assay plate was 1.2 mM IPTG, 1.0 mM Zn(II) and 1.0 µg 
trimethoprim. 
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Figure 2.11.  Theory behind the Operation of Protein-Fragment Complementation 
Assays. 
Shown on the left-hand site, two plasmids harboring are shown, each possessing the 
same CDG clone on its N-terminus (multi-colored arrow).  The difference between 
each vector is in its N-terminal fusion, shown to be one half of the reporter enzyme 
murine dihydrofolate reductase.  The assay begins with the cotransformation of equal 
quantities of plasmid within competent bacteria.  Upon plating transformed mixtures 
on assay plates, IPTG-induced expression begins where the cell relies on the dimer-
directed reassembly of a nascent murine dihydrofolate reductase since the E. coli’s 
DHFR has been inactivated through TMP inhibition.  Growth on assay plates 
signifies that dimerization within the assay was successful. 
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Chapter 3 
 
Results 
 
 
3.1. MBP-CDG Expression and Purification 
 
 3.1.1. Expression of MBP-CDG 
 Large amounts of soluble fusion protein were produced upon induction of 
typically a four-liter bacterial culture containing the MBP-CDG pET19b vector.  At high 
induction conditions of 1mM IPTG supplemented with 1mM Zn(II)-sulfate, MBP-CDG 
would appear proteolytically clipped upon purification of the HIS-tagged protein.  
According to SDS-PAGE, three bands would appear when run: one at the expected 
molecular weight of 57 kDa, along with a minor band visibly lying just below the 57 kDa 
product (Figure 3.1).  The third band would be present low on the gel and is predicted to 
be the HIS-tag due to its small MW.  The unwanted proteolytic clipping was found to 
occur at the N-terminus of the protein at the Enterokinase K (rEK) proteolysis site which 
separates the HIS-Tag from the malE fusion gene.  There is evidence that the rEK site 
was producing the cleaved product upon purification because induced rEK proteolysis at 
room temperature for approximately 48 hours would only produce two bands: the desired 
MBP-CDG at an estimated molecular weight of 55 kDa and the HIS-tag band at a very 
low molecular weight (Figure 3.1).  
 The expression of the MBP-Zn(II)CDG construct needed to be altered to attain 
soluble fusion protein that did not produce a cleavage product.  Less strenuous induction 
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conditions were tested to determine if non-clipped MBP-Zn(II)CDG could be produced.  
Induction of fusion-protein production proceeded in a similar fashion where the 
concentration of IPTG added was decreased to a final 0.2 mM in culture while 
maintaining a sufficient usable pool of Zn(II) (1 mM) for MBP-CDG to sequester .  
Induction was allowed to proceed for the 2.5 hours at 37° C.  Results produced large 
amounts of soluble, non-cleaved protein despite the much lower induction concentrations 
(Figure 3.2). 
 Affinity purification could proceed using either of two different affinity protocols.  
The most common form of affinity purification that produced the cleanest, quickest 
turnover from lysed bacteria to pure protein was to use the HIS-tag based upon purity of 
protein via SDS-PAGE.  HIS-tags operate upon the binding of a nickel(II) nitrilo triacetic 
acid complex bound to resin beads.  The Ni(II) conjugated to agarose beads binds the 10x 
HIS-Tag with high affinity.  Elution conditions involved the addition of 250 mM free 
imidazole to wash buffer which freed the HIS-tagged protein from the resin.  In addition, 
purification was regularly performed using gravity rather than employing a low-pressure 
pump system. Regardless of method, HIS-tag affinity purification provided high purity. 
 Alternatively, MBP is itself an affinity tag and relies upon conjugated amylose 
beads as a resin.  The MBP binds maltose and other sugar derivatives such as amylose 
with high affinity as well and allows for affinity purification of any MBP-fused protein, 
similar to a HIS-tag.  The HIS-tag method of affinity purification was selected because of 
its rapidity of use since amylose resin-based affinity columns required a low- 
 
 
51 
                      1        2           3          4           5 
 
Figure 3.1. Analysis and Purity of MBP-Zn(II)CDG Protein. 
Pictured is a 12% Coomassie Blue stained Tris Glycine gel prepared according to the 
Molecular Cloning Manual57.  Lane 1: EZ-Run® Molecular weight marker (Fisher 
Scientific, molecular weights from bottom to top in kDa: 20.0, 26.0, 36.0, 47.0, 85.0, 
118.0); Lane 2: Pure, proteolytically clipped MBP-CDG when induced at 1 mM 
IPTG; Lanes 3-5: Time dependent induced rEK digestion for removal of the N-
terminal HIS-tag, samples taken at times t = 12 hours, 24 hours and 48 hours, 
respectively.  
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Figure 3.2. Pure MBP-Zn(II)CDG Fusion Protein using Lower Induction 
Conditions. 
Pictured is a 12% Coomassie Blue stained Tris-Glycine gel of pure MBP-Zn(II)CDG. 
Lane1: EZ-Run® Molecular Weight Marker (molecular weights from bottom to top 
in kDa: 20.0, 26.0, 36.0, 47.0, 85.0, 118.0); Lane 2: pure MBP-CDG protein (Lane 2) 
using a lower induction concentration of 0.2 mM. 
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pressure pump.  In addition, Ni2+-NTA resins can be quickly regenerated since Ni2+ tends 
to leach away from the resin beads but can be recharged utilizing the provider’s protocol.  
Amylose resin was not reusable after 2-3 purifications.  Most importantly, HIS-Tag 
purification regularly provided high levels of purity as evidenced in Figure 3.2.     
 Protein quantification was done by assaying the protein’s reduced cysteine 
content.  Since each protein contains a total of four cysteines, the 2,2’-dithiodipyridine 
assay can be used to determine the reduced cysteine content within solution74.  Since the 
MBP-CDG proteins are expressed and purified with bound Zn(II) within its metal-
binding site, it is possible to calculate each protein preparation’s molar concentration 
based upon its reduced cysteine content, assuming four reduced cysteines per mole of 
protein.    
 Upon protein purification, dialysis was set up against 150 volumes of 50 mM Tris 
pH 7.8, 300 mM NaCl, 0.01%(v/v) β-mercaptoethanol.  Dialysis buffer was changed 
once every 4-6 hours and repeated three times to insure the removal of imidazole. β-
mercaptoethanol acted as a reducing agent in solution which provided protein preps with 
a longer half life, limiting zinc loss across the experimental period. When stored at 4° C 
for greater than 10 days, the fusion protein slowly lost Zn(II) (unpublished observations) 
and subsequently the cysteines would oxidize and the protein would become prone to 
aggregation.  Once the protein lost most of its Zn(II), subsequent attempts to re-titrate 
metal failed because of the aggregation phenomenon. 
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3.2. Results from Isothermal Titration Calorimetry Studies 
3.2.1. Design and Approach 
 Isothermal titration calorimetry experimentation was the principal technique used 
in this research to study the in vitro homo-dimer association and dissociation of the CDG 
protein.  Prior to investigating this particular model, it was important to begin work on 
the instrument with a well-characterized homo-dimerization model to insure that the 
logistics and data analysis proceeds smoothly.  Bovine pancreatic α-chymotrypsin was 
chosen as the working positive model.  Alpha-chymotrypsin, a serine protease similar to 
trypsin, exists as a catalytically inactive monomer.  Dependent upon metabolic needs, 
once the organism starts synthesizing large quantities of chymotrypsin, cellular 
concentrations rise allowing the enzyme to dimerize and become active75, 76.  Its catalytic 
substrate binding pocket, formed through the dimer interface, is not able to process 
degraded proteins. 
 Experimental results shown in Figure 3.3 mimic those published findings in cited 
in Figure 2.2 of this dissertation.  In addition, the calculated dissociation constant from 
the experimental ITC run conducted was 47 µM compared to 53 µM found in the 
literature55.  These results provided confidence that the MicroCal MCS ITC was sensitive 
enough to perform dimer dissociation reactions regularly with accurate analysis. 
 According to literature, high concentrations within the range of 600-900 µM are 
necessary to produce the quality of data that could be successfully fit with a theoretical 
dimer dissociation equation55.  Figure 3.4 shows a final raw thermogram (upper panel) 
combined with the non-linear curve fitting analysis (lower panel) of the dimer 
dissociation of α-chymotrypsin at a starting concentration of 700 µM.  The final 
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Figure 3.3. Experimental ITC Data of Dimeric α–Chymotrypsin. 
The α-chymotrypsin titration was programmed to dispense 25 equal 10 µL injections 
with the exception of the first injection which is usually ignored due to dilution 
effects from the injection syringe.  Starting protein concentration was 622 µM.  
Internal experimental temperature was established at 25° C.  Upper Panel: Presented 
is the raw thermogram of the titration of concentrated dimeric enzyme.  Upward 
spikes indicate an endothermic reaction where the instrument is providing positive 
power to the cell to balance the loss of heat.  Lower Panel: Each point contains the 
integration of the area under each titration point, plotted versus molar ratio of 
monomer to dimer within the cell.  Origin® Version 7.0 software equipped with a 
specific non-linear fitting macro for dimer dissociation reactions provided the data 
analysis.  The red fit line indicates experimental α-chymotrypsin results. 
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fitting parameters produced the following results: dissociation constant 47 µM; enthalpy 
of reaction 9.1 x 104 kJ/mole.  Despite the visually poor curve fitting, the resultant data 
corroborates previously reported results for the dissociation constant of the α-
chymotrypsin protease. 
 
3.2.2. ITC Results of MBP-Zn(II)CDG Dimer Dissociation 
 A similar experimental setup was done for the MBP-Zn(II)CDG experiments 
compared to those from the alpha-chymotrypsin experiments.  Starting concentrations of 
MBP-CDG began at a minimum of 1 mM and applied to all combination of aliphatic-
deletions, metal-binding site deletions and point mutations within the aliphatic region.  
Since the dissociation constants for those constructs are expected to be higher than that of 
the MBP-CDG, larger initial protein concentrations will provide a better non-linear curve 
fitting session.  Results of the full length MBP-Zn(II)CDG protein indicate strong 
dimerization, with a final dissociation constant of 89 ± 22 µM (Figure 3.2).   
 As a negative control, unfused MBP was tested alone without CDG using ITC 
(Figure 3.5).  At a similar starting concentration of 1 mM total protein within the 
injection syringe, ITC was tested to prove that the MBP does not facilitate dimerization, 
nor contribute to CDG’s dimerization.  Small downward-pointing spikes indicate weak 
exothermic heat produced as a result of protein dilution within an ITC cell full of buffer.  
Comparison of this data with Figure 3.4 clearly indicates the difference between a 
dimeric protein signature and a non-self-associating protein in ITC.   
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Figure 3.4. Experimental ITC Data of the MBP-Zn(II)CDG Protein. 
Upper Panel: Raw thermogram displaying positive, endothermic peaks upon MBP-
Zn(II)CDG’s dimer dissociating to monomer.  Each ITC reaction has been 
standardized across the duration of CDG mutants to generate 30 injections at 25° C.  
The first injection is 2 uL and is considered erroneous because of dilution phenomena 
occur upon placement of the injection syringe within the cell.  Lower Panel: Non-
linear fitting using the same Origin® Version 7.0 software.  The calculated 
thermodynamic values of this dimer indicate a dissociation constant of 89 ± 22µM.  
The ∆H of the reaction was calculated to be 159 ± 10.3 kcal/mole.  Black lines of fit 
indicate results from the MBP-CDG constructs. 
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3.2.3. ITC Results of GB1-Zn(II)CDG Dimer Dissociation 
 We evaluated an additional fusion construct utilizing GB1 as a solubility 
enhancement tag instead of MBP to show that a multitude of fusions can dimerize as a 
result of the linkage with the CDG sequence.  Experimental ITC runs of the GB1-
Zn(II)CDG purified protein produced dimers, but the interaction did not appear as strong 
as that of MBP-CDG.  At a similar starting concentration of 1mM GB1-Zn(II)CDG, 
strong dimerization similar to the MBP-Zn(II)CDG was observed.  The data analysis in 
Figure 3.4 provided similar thermodynamics in reference to the determined dissociation 
constant of 114 ± 37.2 µM compared to MBP-Zn(II)CDG at 89 ± 22 µM.  Being 
statistically similar to each other, a calculated increase in dissociation constant of the 
GB1-Zn(II)CDG dimer may be contributed to the overall size of CDG’s attached fusion 
protein and may marginally influence the strength of the dimer.  Overall, the MBP-CDG 
construct was selected for ITC biophysical studies because of the better data quality 
obtained. 
 
3.2.4. ITC Results of MBP-Zn(II)CDG without its Aliphatic Region 
(MBP-Zn(II)CDG ∆A.R.) 
 Testing of the metal-binding site’s individual contributions to CDG’s 
dimerization was imperative towards testing the hypothesis of the dimerization domain.  
Enabled through the design of CDG, a simple restriction digest to remove the aliphatic 
region, followed by re-ligation of the vector allowed for the creation of a 
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                                                  Molar Ratio 
 
Figure 3.5. Experimental ITC Data of Maltose-Binding Protein (MBP). 
MBP was expressed and purified by itself and not as a fusion to CDG.  Concentrated 
MBP was tested using ITC to display that it was a monomer at high concentrations.  
Experimental setup is consistent with the ITC setup from Figure 3.4.  Concentrated 
monomeric MBP was titrated into a cell of buffer, similar to a dimer dissociation 
experiment.   
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Figure 3.6. Experimental ITC Data of the GB1-Zn(II)CDG Protein. 
Experimental setup of the GB1-fused with CDG was setup consistent with previous 
ITC experiments described in Figure 3.4.  The upper panel provides evidence of an 
endothermic signal, indicative of dimerization.  The non-linear fit in the lower panel 
produces a dissociation constant of 114 ± 37.2 µM with a reaction enthalpy of 90.5 ± 
16.1 kcal/mole 
. 
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construct that maintained the open reading frame of the metal-binding site with the MBP 
gene.  All methodology used to prepare the MBP-Zn(II)CDG ∆AR was consistent with 
how MBP-CDG was purified.  Upon measuring MBP-Zn(II)CDG ∆AR’s dimer 
dissociation via ITC, it was apparent that dimer dissociation occurred, albeit weaker than 
MBP-Zn(II)CDG (Figure 3.7).  The dimer dissociation model produces a non-linear fit 
for the aliphatic deletion, providing a dissociation constant of 234 ± 11µM compared to 
that of 89 µM for MBP-Zn(II)CDG.  In addition, enthalpy of reaction for the aliphatic 
deletion is 50.7 ± 16.9 cal/ mole, which is one-third of the energy that was produced via 
MBP-CDG.  The intensity of the peaks at the beginning of the experiment performed are 
comparable to MBP-CDG.  However, comparing the differences between MBP-
Zn(II)CDG and its aliphatic deletion in their respective non-linear fits, it is noticeable that 
the slope of the aliphatic deletion curve is not as steep as that of MBP-CDG.   
 
 3.2.5. ITC Results of MBP-CDG without its Metal-Binding Site (MBP-
CDG ∆MBS) 
 A simplistic approach was afforded through the design of the CDG construct for 
removal of the metal-binding site.  For any aliphatic deletion or aliphatic point mutation, 
an additional site-directed mutagenesis reaction can be done with degenerate primers 
containing a single mutant that produces a “STOP” codon just before the first cysteine 
codon within the CDG sequence.  The addition of a stop-codon using site-directed 
mutagenesis eliminated having to use restriction digestion and ligation methods to cut out 
a small sequence which could be tedious. 
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Figure 3.7. Experimental ITC Data of MBP-Zn(II)CDG ∆A.R. 
The whole aliphatic region was deleted from the MBP-Zn(II)CDG construct in order 
to test the metal-binding site’s dimerization capabilities in ITC.  Experimental 
conditions remained consistent with those in Figure 3.4. The nonlinear fitting 
calculations for the data presented above produced a dissociation constant of 234 ± 
11.0 µM.  The enthalpic heat of reaction was 50.7 ± 16.9 kcal/ mole. 
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 Upon purification of this construct, a substantial portion of the prep became 
trapped within the insoluble fraction.  Multiple preps were required and combined to gain 
enough soluble MBP-CDG ∆MBS to perform ITC since a percentage of the expressed 
protein was insoluble according to SDS-PAGE.  This further supports that the metal-
binding site produces specificity towards directing association of specific dimers instead 
of higher order non-specific quaternary structures.  The results of the ITC run did not 
produce stable dimers (Figure 3.8).  Small, downward spikes within the raw thermogram 
do not indicate dimer dissociation but depict a monomeric protein dilution pattern as seen 
in Figure 3.5 for monomeric MBP.  
 
 3.2.6. ITC Results of Partial Aliphatic Deletions in MBP-Zn(II)CDG   
 The CopY gene has been split into two separate functional domains.  Residues 1-
61 are composed of CopY’s DNA-binding domain which shares high homology to other 
known DNA-binding proteins such as λCro repressor.  Therefore, the remaining half of 
the protein, residues 61-144 was labeled its dimerization domain.  The aliphatic-repeat is 
composed of a total of three elongated alpha helices and the protein’s metal-binding site 
at its C-terminus.  Since prior in silico evidence supports that a portion of this region 
behaves like a coiled-coil motif, the aliphatic region of the dimerization domain was 
probed to investigate which portions are most important to dimerization. 
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Figure 3.8. Experimental ITC Data of MBP-CDG ∆MBS. 
The metal-binding site was removed from the MBP-CDG to test the aliphatic-repeats 
ability to form dimers in vitro.  The construct was created by introducing a single 
point mutation before the first cysteine in the MBS to create a STOP codon.  Purified 
MBP-CDG ∆ MBS was analyzed using ITC similar to all other MBP-CDG variants 
tested.  All experimental conditions remained consistent with Figure 3.4. 
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 In relation to the three possible partial aliphatic deletions, the middle deletion 
sequence is presented below.  The second helix deletion was facilitated through the 
restriction digestion of the MBP-CDG plasmid DNA with BsrGI for removal, followed 
by re-ligation of the vector DNA to create the partial aliphatic deletion.  ITC results show 
that dimerization occurs, but with a sacrifice to the dimer’s affinity (Figure 3.9).  
Calculated dissociation constant for this construct was 202 ± 70 µM with a reaction 
enthalpy of 51.9 kcal/mole.  These values are comparable to the MBP-Zn(II)CDG ∆A.R. 
ITC measurements, possibly meaning that the second helix removed from the aliphatic 
region is critical to the overall affinity of the CDG dimer.    
 
3.3. Protein-Fragment Complementation (PFC) Results 
3.3.1. Assaying of Experimental Positive and Negative Control Sets 
 A set of known interacting protein pairs, fused with the two DHFR enzyme halves 
was provided through Dr. Stephen Michnick’s laboratory of the University of Montreal, 
Canada.  The known protein-protein interaction was of a pair of homodimeric leucine 
zipper sequences.  Since a portion of the original hypothesis stated that part of CDG 
mimicked a coiled coil motif (Page 29), meant that protein-protein interactions largely 
aliphatic in nature could operate consistently using this technique.  According to the 
literature available detailing protein-fragment complementation, the negative control to 
perform would be to transform only one half of a DHFR enzyme and not both56, 71.  The 
assay should theoretically produce no colonies, but any residual colony growth will help 
establish a threshold for discerning positively- and negatively-interacting sequences in 
the assay56, 71. 
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Figure 3.9. Experimental ITC Data of MBP-Zn(II)CDG ∆ Helix 2. 
The mid-aliphatic repeat deletion of Helix 2 covers part of CDG’s predicted coiled 
coil.  All experimental setup for this construct was conserved consistent with Figure 
3.4.  Upon fitting the collected data towards the dimer dissociation model, the 
dissociation constant for the mid-aliphatic deletion is 202 ± 70.0 µM, while the 
enthalpic heat of dissociation is 17.4 ± 6.10 kcal/mole. 
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 The set of vectors received from the Michnick lab contained fused basic-region 
GCN4 leucine zippers sequences derived from yeast.  Upon cotransformation, plating of 
assay mixtures and incubation for 48 hours, results show that the controls produced a 
large number of colonies (Figure 3.10).  As indicated, the negative control was to 
transform a single PFC vector instead of both to show that both vectors harboring each 
half of the mDHFR reporter are needed for cell survival within the assay.  Experimental 
results indicate low cellular survival (Figure 3.11), verifying the need for both vectors. 
 
3.3.2. Experimental PFC Data of Full-Length CDG Homodimer 
 Two types of heterodimers can be formed when testing sequences within the 
assay designed for this research.  It is possible to have heterodimers in the fusion 
sequence and heterodimers within the binding site.  In every complementation assay 
shown within this research, there will always be a heterodimer formed within the fusion 
sequence, where each fusion sequence is represented through one DHFR fragment half.  
What is of particular interest to this work is the creation of specific heterodimers in the 
binding site, namely the CDG sequence, either by way of the aliphatic region, or through 
the presence or absence of the metal-binding site.   
 The first set of assays performed investigated an array of homodimeric 
combinations with respect to CDG’s dimerization domain.  Full-length CDG sequences 
were tested against each other, as well as the same aliphatic deletions, and so on.  
Presented are the results for the full-length CDG complementation (Figure 3.12), where a 
large number of transformants indicate a strong interaction occurring within the cell.  
Weaker interactions between tested proteins indicate lower cell survival upon plating.  
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Figure 3.10. Experimental Positive Control of the DHFR[1,2]/DHFR[3]-ZIP 
Complementation. 
Two control vectors containing one of each DHFR enzyme fragment fused to a “ZIP” 
31-residue leucine zipper sequence.  The ZIP sequence is derived from the GCN4 
transcriptional activator from yeast.  Each transformation mixture was dispensed 
upon plates containing 1.2 mM IPTG, 1 mM ZnSO4 and 1 µg/mL trimethoprim and 
incubated at 30° C for 48 hours. 
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Figure 3.11. Experimental Negative Control of Single-Vector Transformation of the 
DHFR[1,2] ZIP Non-Complementation. 
Single transformation of one vector harboring a DHFR enzyme half fused with a 
leucine-zipper dimerization motif produced five colonies.  This negative assay 
indicates that several colonies upon a plate is not a significant sign that protein-
interactions are occurring within the cell.  Experimental conditions mirrored those 
from Figure 3.10. 
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 Performing a similar negative control to the DHFR-ZIP system was necessary to 
do for the CDG system in order to establish a threshold for positive and negative 
interacting partners, in addition to displaying the need for strong colony growth when 
transforming both DHFR vectors.  This was done by transforming DHFR[1,2]CDG alone 
without its complementary DHFR[3]CDG partner (Figure 3.13).   
 
3.3.3. Experimental PFC Data of Global CDG Homodimer Deletions 
 To assess the contributions of each segment of CDG’s dimerization domain, 
specific deletions in the sequence can be created similarly to those for ITC studies.  The 
two most important CDG deletions to test using the PFC technique would be the full-
aliphatic deletion and the metal-binding site deletion.  All data displayed in the remainder 
of this section is indicated via a colony count value, instead of repetitiously showing the 
assay plates themselves.  All results displayed as colony counts for all combinations of 
homo and heterodimerizing assays are displayed in Table 3.1. 
 As indicated in Figure 3.12, the most robust assay combination was the 
homodimeric combination of full-length species.  As expected, the full-length CDG 
homodimers produced an average of 259 colonies.  Results from the full-length 
homodimeric CDG assays coincided with the biophysical analysis of the same construct 
using ITC.  Its calculated results produced the strongest dimer tested at a dissociation 
constant of 89 ± 22 µM.  To preserve the parallel structure between techniques, similar 
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Figure 3.12. Experimental PFC Data Representing Full Length [1,2]-CDG 
Complementation with [3]-CDG. 
A protein-fragment complementation assay was done using the two full-length CDG 
constructs, each fused to either DHFR[1,2] or DHFR[3] lying on a separate vector.  
Experimental conditions, along with the concentrations of IPTG, TMP and ZnSO4 
remained constant from previous experiments done. 
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Figure 3.13. Experimental PFC Data Representing Full Length [1,2]-CDG Non-
Complementation as a Negative Control. 
Mirroring the setup of the complementation assay in Figure 3.11, only one CDG-
fused DHFR fragment plasmid was transformed. Experimental conditions were the 
same for this assay as those that have been presented.  
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homodimeric deletion constructs were tested in protein-fragment complementation assays 
just as they were using ITC.   
 The full aliphatic deletion was created similar to the deletion made in the MBP-
Zn(II)CDG construct.  Upon creating both deletions in both DHFR[1,2] and [3] CDG 
constructs, followed by transformation, there is a noticeable decrease in the colony count 
on the assay plate.  An averaged result of 109 colonies was produced, which aligns with 
the results obtained when the same constructs were used in ITC.  The percentage of 
colonies produced from the aliphatic-deletion compared to those from the full-length 
CDG assay corresponds to the dissociation constants measured by ITC. 
  The next global CDG deletion that was tested was the removal of the metal-
binding site.  The metal-binding site deletion construct, similar to ITC, tested the ability 
of the lone aliphatic-repeat region to maintain dimerization in vivo.  As described before, 
similar molecular biology methods of creating the metal-binding site deletion were 
employed.  An average of 23 colonies resulted on the assay plates, indicating a low level 
of dimerization and subsequently survival of the cells.   
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                                              DHFR[3]-CDG Constructs 
  CDG CDG 
∆ A.R. 
CDG 
∆ MBS 
CDG ∆ 
Helix 1 
CDG ∆ 
Helix 2 
CDG ∆ 
Helix 3 
CDG 
259±35  86±18  19±11  227±26  99±13 75±13 
CDG ∆ 
A.R. 78±19 109±7 0±0  122±11  69±8  86±10 
CDG ∆ 
MBS 20±4 0±0 23±3  12±2  16±3  20±4 
CDG ∆ 
Helix 1 214±23 98±10 18±7 201±15 84±12 117±13 
CDG ∆ 
Helix 2  113±22  112±16  12±9 87±11  141±20 64±11 
D
H
FR
[1
,2
]-C
D
G
 
C
o
n
st
ru
ct
s 
CDG ∆  
Helix 3  91±12  87±19  25±6 95±12  70±15  133±21 
Table 3.1. Protein-Fragment Complementation Assay Results of all Homo-and 
Heterodimer Combinations. 
All colony count combinations for the complementation assays conducted; all values 
are averaged from triplicate runs shown with calculated error.  Those boxes 
emboldened on the diagonal represent homodimeric assays. All other combinations 
are heterodimeric in the binding site and in the fusion protein whereas homodimeric 
combinations are only mixed in the fusion protein.    
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3.3.4. Experimental PFC Data of CDG’s Partial Aliphatic Homodimer 
Deletions 
Given that the complete deletion of CDG’s aliphatic-repeat produces a large 
decrease in dimer affinity, it is necessary to further expound its sequence in an effort to 
locate those portions critical to the interaction.  The first deletion assay conducted was 
the Helix 1 deletion furthest away from the metal-binding site.  According to averaged 
assay results, 201 colonies were produced.  The results from this assay indicate that the 
majority of CDG’s affinity is retained in the absence of this alpha helix, despite the small 
decrease in colony output.  These results match ITC results, displaying that the affinity is 
negligibly perturbed when helix 1 was removed. 
The central alpha helix to CDG’s aliphatic-repeat was the next region tested.  The 
restriction enzyme that facilitated its removal was BsrGI.  According to ITC, its removal 
aligned comparably to the removal of the entire aliphatic-repeat region, which 
highlighted its importance within the dimeric interaction.  In vivo assay results produced 
analogous results with a colony count average of 140.  Being a little stronger of an 
interaction compared to the full aliphatic-deletion in this technique, additional features of 
the aliphatic-repeat participate in dimerization. 
The third helix, the metal-binding site’s nearest neighbor, was the last partial 
aliphatic-deletion to be tested.  Containing a small, shared sequence of amino acids to 
those found in the second helical region, the overlap will help explain similar results to 
the BsrGI sequence.  Testing this aliphatic-deletion within the protein-fragment 
complementation framework produced a similar number of colonies to Helix 2, 133.  
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Having similar homodimeric results shows the importance of the third alpha helix to 
dimerization, in addition to the second.   
 
3.3.5. Experimental PFC Data of Full and Partial CDG Heterodimer 
Deletions 
 All protein-fragment complementation experiments were constructed as fusion-
protein heterodimers.   Heterodimers can differ from homodimers when testing dissimilar 
mutants in CDG’s dimer binding site  Binding-site heterodimers have been tested using 
different combinations of CDG linked to both DHFR[1,2] and DHFR[3].  Generally, all 
combinations of CDG mutants that contained DHFR-CDG sequences with a metal-
binding site produced stronger dimeric interactions in vivo compared to those lacking it.   
 General observations indicate that any heterodimeric combinations tested within 
the aliphatic-repeat have lower colony counts compared to those homodimeric in nature.  
The assay mixture of one Helix 3 deletion with a Helix 2 deletion shows that asymmetric 
dimer construction in vivo can be perturbed compared to those symmetrically-formed 
homodimers.  Also, a mixture of a full-length CDG construct with a helix 1 deletion 
produced lower than expected survivability.   Based upon previous data eliciting helix 1’s 
contribution to dimer formation, it was predicted that the combination would produce an 
equal number of colonies when assayed.  It appears that the spacing and size of each 
CDG sequence tested may influence the eventual folding of each construct’s enzyme 
fragment upon the other.   
 The strength of the heteromeric interactions varied widely based upon the 
composition of the aliphatic repeat being tested.  For instance, assays involving the full-
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length CDG (aliphatic-repeat plus metal-binding site) produced the strongest interactions 
compared to those partial aliphatic-repeat deletions occurring closest to the metal-binding 
site.  Consistent with homodimeric data resulting from ITC and homodimeric protein-
fragment assays, the metal-binding site is necessary to preserve strong affinity dimers.  
One particular combination-of-interest involved one full aliphatic-deletion assayed 
against a metal-binding site deletion.  As expected, the combination did not produce any 
noticeable colony growth, indicating that there is no cross-functional interaction between 
alpha helices and the Zn(II)-bound metal-binding site in vivo.   
 Similar results were observed generally with any combination of deletions that 
involved a construct without a metal-binding site.  Seemingly all assays either involving 
the loss of one or both metal-binding sites produced colony counts no larger than 25.  
Congruent findings between techniques inarguably indicate that CDG’s metal-binding 
site is responsible for the formation of stable two-stranded dimers both in vivo and in 
vitro.  This represents two phenomena; first that only parallel interactions between two 
aliphatic-repeats or two metal-binding sites occur.  Secondly, this reaffirms the assays 
sensitivity where no false positives are detectable, meaning low colony counts as 
observed with the metal-binding site deletions are verifiable results.  
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Chapter 4 
 
Discussion & Significance 
 
4.1. Biophysical Examination of CopY’s Dimer using ITC 
4.1.1. Analysis of Homodimeric CDG Constructs 
Initial studies on the metalated MBP-Zn(II)CDG began with the full-length 
aliphatic repeat + metal-binding site sequence.  Titration calorimetry of this construct 
produced an expected dimer dissociation response as seen in Figure 3.4, based upon both 
the intensity of the raw thermographic data peaks and because of the strength of the 
interaction indicative through the determined dissociation constant.  The MBP-
Zn(II)CDG constructs Kd was determined to be 89 ± 22 µM using a non-linear fitting 
model for a dimer-dissociation reaction.  A similar experiment combining the dimeric 
CDG sequence with an alternative solubility-enhancement tag, GB1, produced results 
comparable with the MBP fusion (Figure 3.5).  Zn(II)-GB1-CDG produced a 
thermodynamic dissociation constant of 114 ± 27 µM, making them very similar.   
As noted in Section 3.2.3., a rationale as to the slight difference in dissociation 
constant may be attributed to the size of the dissociating dimer.  MBP-Zn(II)CDG being 
three-fold larger than GB1-Zn(II)CDG would produce a larger endothermic response due 
to the ITC cell and the buffering solution accommodating a larger volume of protein 
compared to GB1.  In addition, upon dissociation to monomer, a larger protein surface 
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area is created, where increased hydrogen bonding of the buffering components to the 
protein would be created. 
 An experimental control was setup to insure that the obtained clones MBP and 
GB1 were not dimer-forming fusions.  The GB1 protein was selected because of its small 
(56 amino acids), globular nature and is quite different in structure compared to the larger 
MBP.  In separate experiments, each individual fusion without a linked CDG sequence 
was tested within the ITC (Figure 3.5).  Contrary to the thermographic signature 
established by a dimer dissociation reaction, concentrated monomeric proteins simply 
produced small, dilute, exothermic responses, all of equal intensity, indicated that each 
fusion protein does not possess self-associating properties.   
 While progressing through the homodimeric CDG deletion studies with ITC, 
comparison between the full-length metalated fusion protein and its full aliphatic-deletion 
displayed differences in the dimer affinity.  The dissociation constant for the MBP-
Zn(II)CDG ∆A.R. was calculated as 234 ± 11µM, which is roughly 30% of the strength 
as that of the full-length CDG dimer (Figure 3.7).  In addition, a correlation is noticed in 
the calculated reaction enthalpies for both tested proteins, where the enthalpy of the full-
length CDG dissociation reaction was also crudely three-fold larger than the aliphatic 
deletion.  To summarize, it appears as if the full aliphatic repeat contains a sizeable 
contribution to the strength and affinity of the CDG dimer.  This observation is not to 
underestimate the importance of the metal-binding site in its ability to organize 
quaternary structure.  To gain better insight into what the metal-binding site’s 
responsibility was within the dimerization mechanism, the setup was inverted where only 
the aliphatic region in the ITC was examined instead of only the metal-binding site. 
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 The construct that identified the metal-binding site’s relevance to the dimer 
interaction is named MBP-CDG ∆MBS.  Because of the absence of the metal-binding 
site, there was no bound Zn(II) coordinated in each CDG monomer.  When examining the 
raw thermogram, small exothermic peaks are noticeable where the peaks seem to increase 
in intensity as the ITC experiment continues towards completion (Figure 3.8). The ITC 
data coincides with previous studies examining aggregation phenomena where 
exothermic contributions chracterize the interaction, as indicated through the raw 
thermograph77, 78. Concentrated MBP-CDG ∆MBS was injected within the calorimetric 
cell, and during the first initial injections, it appears as if this construct does not dimerize 
as its small exothermic spikes coincide with a non-dimerizing protein.  Since the whole 
thermogram does not produce equally-sized exothermic spikes as they gradually increase 
towards the termination of the titration, there must be other interactions occurring within 
the cell, or possibly the syringe that contains the concentrated sample.   
 In general, the preparation of the MBP-CDG ∆MBS required a larger amount of 
preparative-scale culture compared to other constructs that have the metal-binding site.  
Because this observation was not due to a decrease in the in vitro expression of the 
construct, it was largely due to its tendency to aggregate and become trapped within the 
insoluble fraction of the protein preparation (experimental observation).  The loss of the 
metal-binding site failed to organize MBP-CDG monomers into specific dimers.  Once 
high enough concentrations of soluble MBP-CDG ∆MBS fusion were acquired for ITC, 
the protein became aggregated and formed non-specific higher-order structures upon 
concentrating the samples.  These aggregated forms of MBP-CDG did not spontaneously 
reform into specific two-stranded dimers as indicated during ITC (Figure 3.8), but the 
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equilibrium was pulled strongly towards the formation of non-specific aggregates.  
Because of the radical outcomes observed during the preparation and testing of this 
metal-binding site deletion, the structural and functional features of the terminal metal-
binding site in terms of building stable dimers are better understood.  It appears that the 
metal-binding site itself possesses affinity contributions to the entire CDG dimer, but is 
required initial to establish specific monomer-monomer contacts.  Presently, a functional 
role as been established for CopY’s –CxCxxxxCxC- site apart from its duties related to 
metal-sensing and operon control.    
  
4.1.2. Analysis of Homodimeric Partial-Aliphatic Deletions 
The whole aliphatic-repeat’s importance to the interaction has been displayed 
where further detail can be gained through the testing of each deletion.  Within CDG’s 
aliphatic repeat was the capacity to delete regions of sequence in order to investigate their 
roles in dimerization.  Using a single restriction enzyme at-a-time, one portion of the 
aliphatic-repeat could be removed so as to determine that sequence’s duty to fostering 
dimeric interactions in its absence.  The following order of restriction enzymes 
corresponds to their location within the CDG gene sequence: N—SnaBI-BsrGI-SalI—C 
where the SnaBI restriction enzymes eliminate the gene sequence for the first predicted 
helix and the SalI restriction enzymes deletes Helix 3 (Figure 2.7 & 2.9).   
In vitro testing of the Helix 1 deletion was not conducted since protein-fragment 
complementation assay results indicated it was not a critical element to CDG’s 
dimerization, therefore the first partial aliphatic-deletion tested was the MBP-Zn(II)CDG 
∆ Helix 2.  Being a segment of the aliphatic-repeat within the middle of the aliphatic-
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repeat, it was unknown how much dimer affinity was attributed to this portion.  After ITC 
testing, the results showed similar trends to the total aliphatic-deletion data based upon 
comparison of the dissociation constants (202 ± 70 µM) and enthalpy of reaction values 
(Figure 3.9).  At this point, the first helix of CDG’s aliphatic repeat was ruled out as 
contributory to dimerization, but the second helix contains important coiled-coil affinity 
for dimerization. 
 Further comparison between the middle helix deletion and the total aliphatic 
deletion (Figure 3.7) show that the initial injections of the concentrated Helix 2 mutant 
sample was visibly less intense, despite maintaining a starting protein concentration of 1 
mM.  Secondly, after a 30-injection ITC experiment, the difference in peak intensity 
between the first and last injections was smaller than that of the full-length MBP-
Zn(II)CDG.  Finally, the combination produced a poor dimer dissociation fit of the data 
upon initiating a non-linear fitting session.  Equivalent observations of poor dimer 
dissociation data fitting have been noticed in many of the ITC analyses.  Conversely, 
these results and observations are attributable to an unquestionably weaker dimer.  One 
cannot ignore that the removal of 20-30 residue segments of a protein would not perturb 
the overall folding of a fusion protein, even though the CDG sequence was engineered 
with restriction enzymes around its predicted secondary structure.  Nonetheless, the 
removal of the second helix sequence, aliphatic in structure, perturbs dimer affinity 
negatively in CDG, confirming the hypothesis that the region tested forms a pseudo 
coiled-coil motif.   
 Without testing the MBP-Zn(II)CDG ∆ Helix 3 construct, it was determined that 
its contribution to the dimerization of CDG was high.  In both partial aliphatic deletions 
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tested, the third helical sequence was intact.  Since a 10-residue portion of the Helix 3 
sequence overlaps into the sequence of the second helix, a remaining gap of 12 residues 
needing to be analyzed.  The mutation was created in the protein-fragment 
complementation assay framework, allowing for its testing in stable dimer formation in 
vivo. 
   
4.2. Molecular Biological Examination of CDG’s Dimer using Protein-
Fragment Complementation 
 Many questions surrounded how robust CDG’s specificity was regarding its 
dimerization, specifically if heterodimer construction was possible, given the multiple 
interaction binding sites that it possesses.  Since CDG contains the ability to have 
portions of the sequence removed for testing, an in vivo molecular biology technique can 
be used to test combinations of binding-site heterodimers in their dimer forming 
capabilities.  The protein-fragment complementation assay was chosen because of its 
high operational specificity towards dimerization and for its well-known low probability 
of false-positive results.  More importantly, the use of the same set of mutant constructs 
from ITC studies as in this assay’s framework allows for parallel conclusions to be drawn 
between the two, independent techniques. 
  
4.2.1. Organization of Complementation Assay and Homodimeric Studies 
The premise of this in vivo dimerization assay relies upon the reconstitution of 
two halves of an enzyme, mouse dihydrofolate reducatase (mDHFR), which effectively 
replaces bDHFR inhibited by trimethoprim.  Initial studies using the CDG sequence 
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involve its full-length sequence, the full-aliphatic-deletion mutant and the metal-binding 
site mutant.  Performing these three homo-dimerization assays established a window 
where one could discern between strong-interacting partners and weaker ones.  The 
hypothesis combined with the ITC results, states that the strongest interacting sequence 
would be the full-length CDG homodimer and the weakest being the metal-binding site 
deletion.  Results from the three assays run in triplicate indicated that the full-length 
homodimer assay produced the strongest dimerization based upon the colony-counts on 
each assay plate.  The full-length CDG homodimer produced 259 colonies when assayed.   
 Variations of the CDG sequence were tested as homodimers initially, in a similar 
manner to the ITC experimental setup.  The full-aliphatic deletion, leaving only the 
metal-binding site intact produced an assay cell count of 109 colonies, much less than 
expected compared to the full-length CDG homodimer.  It is apparent that the metal-
binding sites alone produced stable dimers in vivo, albeit weaker than the full-length 
CDG.  The metal-binding site deletion, leaving only the full aliphatic-repeat, produced an 
average of 26 colonies per assay plate, indicating even weaker dimerization.  Appearing 
to be only residual activity, one can rationalize that at the large IPTG concentration, a 
subsequent large amount of protein is being produced.  Of that large pool of 
mDHFR[1,2]- and mDHFR[3]CDG ∆MBS protein within the cell, a very small 
percentage actually produced specific dimeric interactions as evidenced by residual 
activity and growth on the assay plate.  Despite this finding, aggregation effects observed 
in vitro using ITC coincide with the severe loss in cellular growth during the assay.  If the 
26 colonies observed on the assay plate was a false positive response, one would expect a 
much higher colony count since other cellular proteins would be acting as activators 
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instead of the test proteins.  Because the protein-fragment complementation assay is 
highly specific for dimerizing pairs of proteins, many non-specific and higher-order 
quaternary structures are not visible in this assay.  Therefore, ITC results may not depict 
dimerization occurring in vitro for the MBS deletion due to aggregation, but a low 
percentage of dimer does form within a cellular environment as evidenced by the PFC 
data. 
 As a result, a window of visible dimerizing pairs has been established via colony 
count in the assay setup, as well as a threshold where very low colony counts might be 
questioned in its dimerizing capabilities.  Based upon these results, it is of great interest 
to further investigate the aliphatic-repeat region based upon the affinity lost when testing 
its full-aliphatic deletion with this assay. 
  
4.2.2. Analysis of Homo- and Heterodimeric Partial Aliphatic Deletions 
in vivo 
As was conducted previously, three segments of the CDG aliphatic-repeat can be 
individually removed to test the ability for the remaining CDG sequence to dimerize.  
The first construct tested was the ∆ Helix 1 sequence furthest from the metal-binding site.  
Biophysically it was determined that this portion of the aliphatic-repeat did not contribute 
any affinity to CDG’s dimerization based upon the largely retained affinity of the dimer, 
not making it a vital participant in the interaction.  According to the protein-fragment 
complementation, the homodimer interaction between monomers with the same deletion 
remained strong as predicted, but on average not as strong as the full-length protein.  The 
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agreement between the two techniques with regards to the Helix 1 mutant confirms it not 
to be critical to dimerization. 
  The ∆ Helix 2 and ∆ Helix 3 deletions occur within a region of CDG’s aliphatic-
repeat that is predicted to form a coiled-coil motif.  According to the resultant assay data, 
they statistically appear indistinguishable.  Equivalently, prediction output from the 
“COILS” server predicts the existence of one elongated coiled-coil motif along with 
secondary structural predictions showing two alpha helices in the same area62-64.  Upon 
querying either of the single helix/deletions within the COILS server, the coiled-coil 
motif is destroyed.  Therefore, considering this finding, combined with the data 
representative of the second and third helix deletions, there certainly exists a coiled-coil 
or a “pseudo coiled coil.”   
Upon analyzing CopY’s primary sequence, its aliphatic-repeat of leucines, 
isoleucines, and valines are not regularly spaced out, contrary to other regimentally-
spaced coiled coils and leucine zipper proteins.  This fact, combined with its unique 
ability to dimerize and shift conformations in the presence of different metals ligated 
within its metal-binding site is what separates CopY from other similar repressors.  The 
specificity lies within its unevenly spaced β-branched residues and its polar amino acids 
that appear to flank and protect the hydrophobic core of the dimer.  The requirement for 
evenly-sized and aligned monomers to interact with one another is crucial and it 
influences the strength of the protein’s dimerization, which further outlines the specificity 
of the interaction.  But more evident is without the repressor’s C-terminal metal-binding 
site, the direction of all the specificity within the aliphatic-repeat is lost, having a low 
probability that the rest of the two-stranded dimer will form. 
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4.3. Conclusions 
 By using a combination of biophysical and molecular biological techniques, the 
regions contributing to CopY’s dimerization have been determined.  The design and 
implementation of a variant of CopY’s C-terminus within this research enabled ITC to be 
employed as the principal physical technique.  Despite the non-ideal fitting of the 
resultant data, thermodynamic constants characteristic of all homodimeric combinations 
of CopY’s aliphatic-repeat plus its metal-binding site were explored.  The dominant 
construct producing the strongest affinity was the full-length protein, where all aliphatic 
deletions remained dimerized in the presence of the metal-binding site.  Its removal 
eliminated dimer formation of the lone aliphatic-repeat, producing non-specific 
aggregates (Figure 3.8).   
 A complementary molecular biological technique named protein-fragment 
complementation enabled those CDG mutants tested in ITC to be further analyzed under 
physiological-like conditions.  PFC also possessed the opportunity to create heteromeric 
combinations of the CDG dimer in vivo to assess the specificity built within its sequence.  
All homodimeric assay results correlated well with the ITC data in terms of dimer 
strength and formation.  All metal-binding site deletions, either homomeric or 
heteromeric in nature, produced low growth results, indicating its equilibrium has 
severely shifted towards an aggregated state.  The MBS-deletion results correlate with 
those from ITC, despite the residual activity observed upon the assay plates.  In addition, 
those aliphatic-deletions tested in heterodimeric assays globally produced lower active 
growth complexes compared to their homodimeric counterparts.  Symmetry of the 
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constructed dimer concerning the aliphatic-repeats composition in length influences the 
specificity and stability of the dimer. 
 Over the course of this investigation, the contributions of the aliphatic repeat have 
shown to behave like a coiled coil.  Amphipathic in nature, the design of CDG operated 
upon the hypothesis that a coiled-coil existed.  Its design allowed for the rational removal 
of regions of the aliphatic-repeat.  Through studying combinations of deletions using both 
techniques, it appears that the coiled-coil spans an adjacent 32-residue sequence N-
terminal to the metal-binding site.  Noticeable decreases in affinity when studying 
homodimeric partial aliphatic-deletions combined with lowered growth responses from 
PFC affirm that the two segments of the aliphatic-repeat compose its coiled-coil. 
 The most distinctive property discovered of the CopY dimer was the requirement 
of its metal-binding site to provide guidance for the rest of the sequence to assemble.  Its 
ability to organize quaternary structure is highly apparent according to both 
methodologies used.  With the addition of the 13-residue metal-binding motif and C-
terminus, a total 45-residue metal-controlled dimerization sequence has effectively linked 
several otherwise monomeric proteins under a variety of conditions. 
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Chapter 5 
 
 
Future Research Directions 
  
 In this research, the metal-binding site’s specificity for initiating contacts between 
monomers was obvious throughout the investigation behind CopY’s dimerization.  
Further studies might involve which individual residues provide the specificity within the 
–CxCxxxxCxC- metal binding site.  Randomization of the spacer residues indicated by 
“x” while maintaining the spacing of cysteines so as not to perturb metal-binding may 
illuminate some further details into its dimerization mechanism.  A similar set of 
experiments would utilize the swapping of sequences found throughout nature in place of 
CDG’s metal-binding site to determine if its functionality is conserved.  Metal-binding 
experiments involving Zn(II) and Cu(I) substitution within a series CDG chimeric 
proteins.  Metal-binding may be perturbed or enhanced depending on any allosteric 
interactions from the intermediate residues from the chimeric sequences.  Cysteinyl 
sequences originating from human glutamate decarboxylase II, uncharacterized proteins 
from Arabidopsis thaliana and Xenopus tropicalis, along with thousands of others 
existing in nature would be potential candidates for a chimeric domain swap project. 
 In a parallel research project, one might care to investigate the specificity present 
within CopY’s aliphatic-repeat.  It is known that CopY produces specific two-stranded 
dimers, but does the specificity reside within the metal-binding site based upon initial 
recognition, or does it reside with a stabilizing coiled coil which typically possesses 
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specificity governing the formation of dimers, trimers, tetramers or other structures.  
Substitution of a traditional coiled coil, an average alpha helix or random coil, in place of 
CopY’s aliphatic-repeat would illustrate the amount of interaction specificity present 
within the region. 
 To investigate the sequence of dimer binding involving how CopY’s folds 
together, a kinetics study would be advantageous towards studying the rates at which a 
full-length CDG dimer folds compared to a whole aliphatic-deletion.  Such a study would 
confirm the hypothesis which states that the metal-binding site initiates the dimerization 
and organizes quaternary structure, which was a concluding theory based upon the results 
reported in this dissertation. 
 Lastly, to further investigate the structure of the aliphatic-repeat, a circular 
dichroism (CD) study of CDG and its derivatives would be useful.  Able to monitor 
secondary structural composition, CD would enable confirmation of the hypotheses 
stating the alpha helical content of CopY.  In addition, structural information could be 
gained through pursuing crystallographic studies of CopY’s metal-binding site fused to a 
solubility-enhancement tag.  For instance, high protein concentrations and purity would 
be necessary for achieving x-ray quality crystals for structural determination.  Several 
attempts have been carried out previously utilizing nuclear magnetic resonance (NMR) in 
order to gain structural information with little success.  Low resolution between 
neighboring resonances indicates high flexibility within the metalated protein sample.  It 
appears structural determination efforts should be focused towards using x-ray diffraction 
since other similar repressors such as S. aureus Cd(II)CadC and Zn(II)CzrA, S. elongates 
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apo and Zn(II)SmtB and M. tuberculosis Cu(I)CsoR have had their structures solved 
through it9, 42, 47, 54.   
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